25 January

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Interplay between post-myocardial infarction ejection fraction and atrial fibrillation: implications for ischemic stroke Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public grant(s) – National budget only. Main funding source(s): Singapore Ministry of Health’s National Medical Research CouncilBackgroundThere are little data on the interplay between post-acute myocardial infarction (MI), left ventricular (...)
• 01:00
  Different cellular landscape of four types of non-diseased cardiac valves contributes to their differences in susceptibility of pathological remodeling and disease Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Foundation. Main funding source(s): National Natural Science Foundation of ChinaBackgroundExploring the mechanisms of valvular heart disease (VHD) at the cellular level may be useful to identify new therapeutic targets; however, the (...)
• 01:00
  Preliminary results of whole exome sequencing in a clinical hypertrophic cardiomyopathy cohort in India Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundHypertrophic cardiomyopathy (HCM), characterized by unexplained left ventricular hypertrophy and outcomes ranging from normal life expectancy to heart failure and sudden cardiac death, has a global prevalence of about 1 in (...)
• 01:00
  Characteristics and outcomes of aortic stenosis patients with and without stroke Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public Institution(s). Main funding source(s): Sia CH was supported by the National University of Singapore Yong Loo Lin School of Medicine’s Junior Academic Faculty SchemeBackgroundAortic stenosis (AS) is related to several (...)
• 01:00
  Cardiac valve surgery in Far North Queensland, Australia. A retrospective audit of rheumatic heart disease prevalence, patient demographics and surgical management Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundRheumatic heart disease (RHD) is a preventable valve disease following acute rheumatic fever. It results in >300,000 deaths annually worldwide (1). While commonly encountered in the developing world, the prevalence in (...)
• 01:00
  Intravascular lithotripsy in calcified coronary lesions-A single tertiary care center experience from India Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.AimsSevere coronary calcification is a serious impediment to optimal stent expansion and can lead to stent failure and adverse outcomes. We hereby present Indian experience with intravascular lithotripsy(IVL) for the treatment of (...)
• 01:00
  Comparison of transcatheter, minimally invasive and conventional surgical aortic valve replacement: a systematic review and network meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Background/IntroductionThe landscape of aortic valve replacement (AVR) has evolved dramatically over the years, but long-term outcomes have yet to be comprehensively explored.PurposeTo compare long-term mortality among three AVR (...)
• 01:00
  Safety and efficacy of cerebral embolic protection devices in transcatheter aortic valve implantation: a meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundStroke during Transcatheter Aortic Valve implantation (TAVI) is not an uncommon complication with potential devastating consequences. With the extension of TAVI to the low-risk patient, stroke prevention takes on increasing (...)
• 01:00
  Prognostic value of longitudinal assessment of inflammatory and nutritional status in patients undergoing valvular heart surgery Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundNovel strategies to improve the long-term risk stratification of valvular surgery are urgently needed as a result of the increasing prevalence of valvular heart diseases globally.PurposeThis study aimed to evaluate the (...)
• 01:00
  Implementation evaluation of mhealth interventions in the secondary prevention of coronary artery disease: a supplementary review Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public Institution(s). Main funding source(s): La Trobe UniversityIntroductionmHealth technologies have evolved rapidly in recent years and are now widely implemented for the secondary prevention of coronary artery disease (CAD). While (...)
• 01:00
  Prospective evaluation of digital therapeutic intervention on blood pressure control in Indian patients with uncontrolled primary hypertension Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): Terrals Technologies Private LimitedBackgroundDigital therapeutics (DTx) has emerged as a new approach in recent years making use of connected devices, smartphone software and (...)
• 01:00
  Evaluation of cardiovascular risk scores after implementation of digital therapeutic intervention in patients with uncontrolled primary hypertension Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): Terrals Technologies Private LimitedBackgroundCardiovascular risk scores serve as a useful tool to reinforce the importance of lifestyle modifications and treatment compliance. (...)
• 01:00
  The global syndemic of metabolic diseases in the young adult population: a consortium from the Global Burden of Disease 2000-2019 Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundA large proportion of premature deaths are related to metabolic diseases in the young adult population. We examined the global trends and mortality of metabolic diseases using estimates from the Global Burden of Diseases, (...)
• 01:00
  Heart failure (MYHF) registry: shedding light on lipid profiles and in-hospital outcome of heart failure patients Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Private company. Main funding source(s): Novartis Corporation Sdn BhdBackgroundHeart failure is a debilitating disease associated with multiple comorbidities and poor prognosis. Dyslipidemia, is the top 5 most common comorbidities, (...)
• 01:00
  Pattern of life style in patients from one subset of rural Tamil Nadu-India, after coronary angioplasty Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundLife after percutaneous coronary angioplasty (PTCA) has been sparsely studied unlike the plethora of studies after coronary bypass surgery (CABG). It is mandatory that the patient make life style changes and be drug (...)
• 01:00
  Antithrombotic monotherapy for stable coronary artery disease and atrial fibrillation patients with and without prior coronary artery revascularization: Insights from the AFIRE trial Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Foundation. Main funding source(s): The Japan Cardiovascular Research Foundation under a contract with Bayer YakuhinBackgroundThe AFIRE (Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery (...)
• 01:00
  Nationwide trends of gatekeeper to invasive coronary angiography in suspected coronary artery disease Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Background and ObjectivesReal-world trends in the utility and type of gatekeeping studies in invasive coronary angiography (ICA) requires further investigation.MethodsWe identified outpatients who underwent noninvasive cardiac tests (...)
• 01:00
  Abnormal left atrial strain is associated with eventual diagnosis of atrial fibrillation in patients with embolic stroke of undetermined source Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundPatients with embolic stroke of undetermined source (ESUS) have no immediate attributable cause despite initial evaluation. Occult paroxysmal atrial fibrillation (pAF) diagnosed on prolonged electrocardiographic monitoring (...)
• 01:00
  Long-term results of zero-fluoroscopy catheter ablation in pregnant patients with arrhythmias: a 2-year follow-up study Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundIncidences of rhythm disturbance in pregnant are commonly seen. Catheter ablation of arrhythmias has been shown to be effective and safe. Data on perinatal outcomes and results of zero-fluoroscopy catheter ablation in (...)
• 01:00
  The use of hatch score for the prediction of post operative atrial fibrillation (poaf) after coronary artery bypass graft: a meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Background and AimsAtrial fibrillation (AF) is the most common sustained cardiac arrhythmia in post-cardiac surgery. It is associated with substantial morbidity and mortality, thus portending a significant burden to patients and the (...)
• 01:00
  Implementation of point-of-care INR testing to improve effectiveness of anticoagulation clinic Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionOral Vitamin K antagonist (VKA) is still widely used for anticoagulation. Anticoagulation clinics are set up to monitor patients’ INR and adjust their VKA doses accordingly. Anticoagulation clinic in our centre introduced (...)
• 01:00
  Comparison of adhesive single-lead cardiac ECG patch device with Holter monitoring for detecting atrial fibrillation after an acute cerebral ischemic event: An interim analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public grant(s) – National budget only. Main funding source(s): Ministry of Health MalaysiaBackgroundStroke secondary to atrial fibrillation (AF) is common and often associated with higher risk of stroke recurrence. Detection of AF is (...)
• 01:00
  Influence of non-apical permanent pacing on left ventricular systolic impairment Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundRight ventricular apical (RVA) pacing deleterious effects on left ventricular ejection fraction (LVEF) had been demonstrated. Non-apical pacing, such as right ventricular mid-septal (RVMS) and His Bundle pacing, appear as (...)
• 01:00
  Advantages of leadless pacemakers compared to conventional pacemakers Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundLeadless pacemakers (L-PM) are a new safe alternative technology for pacing the right ventricle. However, not enough information is available on their potential benefits for quality of life (QoL) in patients with L-PM. The (...)
• 01:00
  Effects of SGLT2 inhibitors on heart failure symptoms, quality of life and exercise capacity in patients with heart failure and preserved ejection fraction: A meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionPatients with HFpEF usually have severe exercise intolerance which leads to poor quality of life. While SGLT2 inhibitors in HFrEF patients have been proven beneficial, with HFpEF it remains uncertain. This meta-analysis (...)
• 01:00
  Efficacy of sodium glucose cotransporter 2 inhibitors for heart failure with preserved and mildly reduced ejection fraction: a systematic review and meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundSGLT2 inhibition has been a breakthrough approach in the treatment for heart failure. A most recent trial of Dapagliflozin has shown its robust benefit in patients with HFpEF and HFmrEF. However, the positive outcomes of (...)
• 01:00
  SGLT2 inhibitors among patients with heart failure with preserved ejection fraction: a meta analysis of randomised controlled trials Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundSodium glucose co-transporter 2 (SGLT2) inhibitors have been recommended in the practice guidelines for the treatment of patients with heart failure with reduced ejection fraction, however their effects among patients with (...)
• 01:00
  Clinical characteristics, management, and outcomes of acute heart failure patients in Central Asia Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundCardiovascular disease (CVD) is the leading cause of death in Central Asia. In 2019, crude mortality rate in the region was 348.13 per 100,000 population. Heart failure (HF) is important CVD subtype owing to even worse (...)
• 01:00
  Key comorbidities and laboratory findings: insights from first prospective, observational and Multi-Center Malaysia Heart Failure (MYHF) registry Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Private company. Main funding source(s): Novartis Corporation Sdn BhdBackgroundIn real world settings, factors that may affect prognosis of HF patients include comorbidities, lack of guideline-directed medical therapies (GDMT) and (...)
• 01:00
  Estimation of brain natriuretic peptide values from N-terminal pro brain natriuretic peptide levels and other factors Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundsBoth brain natriuretic peptide (BNP) and N-terminal proBNP (NT-pro BNP) are established biomarkers that are necessary in the diagnosis and management of heart failure (HF). Recently with the introduction of angiotensin (...)
• 01:00
  Cardiac tamponade in a multiracial population- epidemiology, clinical characteristics and survival outcomes - a single centre experience Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundCardiac tamponade is a medical emergency which requires prompt medical intervention via pericardiocentesis. Diverse etiologies has been attributed, with malignancy and Tuberculous effusions being the leading causes. The aim (...)
• 01:00
  Long term survival of antenatally diagnosed functionally single ventricle congenital heart disease Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundAntenatal diagnosis of single ventricle congenital heart disease (CHD) allows prenatal counselling, better parental preparation and support as well as improved perinatal management. Expectant parents frequently ask about (...)
• 01:00
  Cardiovascular profile and electrocardiographic findings of hospitalized adult patients during the surge of delta and omicron variants of COVID-19 in a COVID-19 tertiary referral center Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundCOVID-19 has been reported to cause cardiac injury. It can be detected by an electrocardiogram (ECG), which may show markers that may predict clinical outcome. Robust data on the ECG abnormalities among COVID-19 patients (...)
• 01:00
  Seven-day holter monitoring detects more significant arrhythmias than 24-hour and 3-day monitoring Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Background/Introduction24-hour Holter monitors have been used widely to assess patients with suspected and known arrhythmias. Recent studies have shown increased yield of arrhythmia detection with longer durations of Holter (...)
• 01:00
  Association between triglyceride and all-cause mortality and cardiovascular outcomes in heart failure patients: a territory-wide study in Hong Kong Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.ObjectivesTo determine the association between levels of triglyceride (TG) and all-cause mortality and cardiovascular outcomes. To evaluate the concentration of TG associated with the lower range and lowest risk of adverse outcomes (...)
• 01:00
  Association between ACE I/D gene polymorphism and coronary artery lesion characteristics in patients with acute myocardial infarction Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundAcute myocardial infarction (AMI) remains a public health issue with high morbidity and mortality rates and significantly reduces patients' health-related quality of life. The identification of factors influencing coronary (...)
• 01:00
  The surprises in optical coherence tomography (OCT) findings in patients presenting with in-stent restenosis: the road less travelled Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundMorphological features of neointimal tissue play a pivotal role in the pathophysiology of In-Stent Restenosis (ISR) after percutaneous coronary intervention, hence understanding these features and patterns is (...)
• 01:00
  A novel cardiac arrest severity score for the early prediction of hypoxic-ischemic brain injury and in-hospital death Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundOut-of-hospital cardiac arrest (OHCA) outcomes are unsatisfactory despite postcardiac arrest care. Early prediction of prognoses might help stratify patients and provide tailored therapy.PurposeIn this study, we derived and (...)
• 01:00
  Novel serum biomarkers for predicting prognosis in post cardiac arrest patients Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.ObjectiveTo determine the clinical feasibility of novel serum biomarkers by comparing them with conventional serum biomarkers in out-of-hospital cardiac arrest (OHCA) patients treated with target temperature management (...)
• 01:00
  In-hospital outcomes of rotational atherectomy in relation to operator volumes: data from an asian national databank Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionStudies investigating the relationship between percutaneous coronary intervention operator volumes and patient adverse events largely, but not consistently, suggest an inverse association. A recent study of rotational (...)
• 01:00
  High thrombotic risk is associated with higher prevalence of suboptimal stent results in patients with high bleeding risk Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundShorter duration of dual antiplatelet therapy after drug-eluting stent implantation is required in patients with high bleeding risk (HBR) irrespective of the presence of concomitant high thrombotic risk (HTR). The (...)
• 01:00
  Effects of sodium glucose cotransporter 2 inhibitors on the risk of hyperkalemia in patients on mineralocorticoid receptor antagonist: a systematic review and meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundOccurrence of hyperkalemia has been a great limitation in the full implementation of a guideline-directed medical therapy especially in patients with heart failure. Recent developments have exhibited the positive role of (...)
• 01:00
  Machine learning accurately quantifies epicardial adipose tissue from non-contrast CT images in coronary artery disease Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Other. Main funding source(s): Industry Alignment Fund – Pre-positioning ProgrammeBackgroundEpicardial adipose tissue (EAT) is the visceral fat deposit within the pericardium that surrounds the heart and the coronary arteries. EAT volume (...)
• 01:00
  Applying an interpretive machine learning algorithm to predict in-hospital mortality in elderly asian patients with acute coronary syndrome (ACS) Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public grant(s) – National budget only. Main funding source(s): Mosti TED1 grantBackgroundNo study has used interpretative Machine Learning (ML) algorithms to predict in-hospital mortality for the Asian elderly (65+). TIMI predicts (...)
• 01:00
  System delays and target points: analysis of STEMI response program a single center Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionSTEMI carries the highest risk among the AMI and the mortality is influenced by many factors. Hospital delays are the most easily audited and should be analyzed and improved.MethodologyParticipants were adults aged > 19 (...)
• 01:00
  The diagnostic utility of cardiac imaging (echocardiogram and cardiac MRI) in COVID 19 patients and cardiac complications: retrospective cohort study in Saudi Arabia Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Background/IntroductionCoronavirus disease (COVID-19) continues to cause considerable morbidity and mortality worldwide. The complication in patients with severe COVID-19 disease include arrhythmias, peri-myocarditis (PM), and heart (...)
• 01:00
  Electrocardiographic predictors of disease severity, mortality, and advanced ventilatory support among hospitalized covid-19 patients: a two year single center retrospective, cohort study Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionFor detecting myocardial injury in severe and critical COVID-19, the electrocardiogram (ECG) is neither sensitive nor specific; but in a resource-poor environment, it remains relevant. Changes in the ECG can be a (...)
• 01:00
  The single-syringe versus the double-syringe techniques of adenosine administration for supraventricular tachycardia: a systematic review and meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionIntravenous double-syringe technique (DST) of adenosine administration consists of an intravenous bolus of adenosine via three-way stopcock followed by an immediate 10-20ml sodium chloride 0.9% flush and is the (...)
• 01:00
  Estimated glucose disposal rate, a novel biomarker for insulin sensitivity, predicts risk for incident heart failure in patients with type 2 diabetes Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public grant(s) – National budget only. Main funding source(s): Singapore National Medical Research CouncilSingapore Khoo Teck Puat Hospital STAR grantBackgroundAlthough a low insulin sensitivity (insulin resistance) has been considered as (...)
• 01:00
  Sex differences in the evaluation and outcomes of multi-ethnic asian patients undergoing stress echocardiography Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Background/IntroductionStress echocardiography is an important test used in the evaluation of myocardial ischemia. Despite this, not much is known about sex differences between men and women undergoing stress echocardiography, with (...)
• 01:00
  Electrocardiographic findings and incidence of new-onset atrial arrhythmia among patients with severe leptospirosis who underwent veno-venous extracorporeal membrane oxygenation Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundLeptospirosis is a zoonotic disease caused by Leptospira species that remains endemic in the Philippines. In severe cases, patients present with multiple organ system failure such as acute renal failure and acute (...)
• 01:00
  Efficacy of cryoablation versus antiarrhythmic therapy for treatment of atrial fibrillation: a systematic review and meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionAtrial fibrillation (AF) is a common arrhythmia that causes various complications if left untreated. Current primary care guidelines recommend administration of antiarrhythmic drugs (AAD) as the preferred treatment (...)
• 01:00
  Optimal international normalized ratio target in east asian populations with atrial fibrillation: systematic review and meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundAlthough current guidelines recommend the use of direct oral anticoagulants in patients with non-valvular atrial fibrillation (NVAF), the use of vitamin K antagonists (VKA) is still very widespread, especially in low to (...)
• 01:00
  Frequent need for apixaban dose adjustment for atrial fibrillation in an unselected acute medical admission population during the COVID 19 pandemic Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundDuring the COVID-19 pandemic, systematic switching patients of eligible patients with atrial fibrillation from warfarin to direct oral anticoagulants (DOACs) was encouraged to simplify drug dosing and obviate the need for (...)
• 01:00
  Factors Associated with Coronary Artery Calcification and Cardiovascular Outcome Among Pre-Dialysis Chronic Kidney Disease Patients in Phramongkutklao hospital Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundCardiovascular disease is the leading cause of death in chronic kidney disease (CKD) patients. Calcified coronary artery is highly prevalent and more severe among these group. Coronary calcium score was used as a risk (...)
• 01:00
  Impact of novel risk factors of atherosclerosis on severity of coronary artery disease in young Indian patients suffering from Myocardial Infarction Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundAsian Indians are affected at least a decade earlier with cardiovascular diseases (CVD), in their most productive midlife years as compared to people of European ancestry. This is the first study from Indian sub-continent (...)
• 01:00
  Contemporary review of the management of left ventricular thrombus Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionLeft ventricular thrombus (LVT) is a known complication of acute myocardial infarction (AMI) and other cardiomyopathies. LVT increases the risk of stroke and systemic embolism, hence treatment with oral anticoagulation is (...)
• 01:00
  Prasugrel-based de-escalation vs. conventional therapy after percutaneous coronary intervention in ACS patients according to the renal function Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Private company. Main funding source(s): A consortium of six companies in Korea (Daiichi Sankyo, Boston Scientific, Terumo, Biotronik, Qualitech Korea, and Dio).BackgroundPatients with coronary artery disease and impaired renal function (...)
• 01:00
  Natural history of functional mitral regurgitation: a systematic review and individual patient data meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public Institution(s). Main funding source(s): Ching-Hui Sia was supported by the National University of Singapore Yong Loo Lin School of Medicine's Junior Academic Fellowship Scheme.BackgroundFunctional mitral regurgitation (FMR) (...)
• 01:00
  Effects of medical therapy, transcatheter intervention, and surgery on outcomes of patients with functional mitral regurgitation: a systematic review and network meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public Institution(s). Main funding source(s): Ching-Hui Sia was supported by the National University of Singapore Yong Loo Lin School of Medicine's Junior Academic Fellowship Scheme.BackgroundFunctional mitral regurgitation (FMR) is the (...)
• 01:00
  Predictors of mortality in Vietnamese patients with infective endocartis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundInfective endocarditis (IE) has been associated with an elevated mortality rate despite major advances in diagnostic and therapeutic methods for the past decades.Purposeto evaluate predictors of in-hospital all-cause (...)
• 01:00
  Statin use after valvular heart surgery is associated with a decreased risk of prosthetic valve endocarditis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public hospital(s). Main funding source(s): Sanming Project of Medicine in Shenzhen, China;HKU-SZH Fund for Shenzhen Key Medical DisciplineBackgroundProsthetic valve endocarditis (PVE) is a rare but serious complication following valvular (...)
• 01:00
  Comorbidity patterns in older patients with diabetes in primary care: a cross-sectional study Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundDiabetes is a well-known risk factor for cardiovascular diseases and continues to be a global public health challenge. In Australia, prevalence rates of diabetes increase with age with almost 1 in 5 older people reported (...)
• 01:00
  Contrast induced nephropathy in older Vietnamese patients undergoing coronary angiography and intervention Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundThe prevalence of coronary heart disease increases with age and older people accounted for a large proportion of patients presenting with coronary heart disease. Advancement in percutaneous coronary intervention (PCI) has (...)
• 01:00
  Pre-diabetes is associated with increases cardiac event in cancer patients treated with anthracyclines Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public hospital(s). Main funding source(s): University of Hong Kong, Queen Mary HospitalObjectiveTo evaluate the association between pre-diabetes and cardiovascular events in patients treated with anthracyclines containing chemotherapy (...)
• 01:00
  Cardiovascular disease in older patients with end-stage renal disease and chronic dialysis in Vietnam Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundPatients with chronic kidney disease, especially end-stage renal disease, exhibit a very high cardiovascular risk. In Vietnam, chronic kidney disease and cardiovascular disease (CVD) are very common in older people. (...)
• 01:00
  Intraventricular pressure gradient: a novel colour M-mode echocardiographic-derived imaging modality to assess and predict the alterations following acute myocardial infarction Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundMyocardial infarction (MI), caused by partial or total interruption of myocardial blood supply, is among the leading causes of morbidity and death. It can go silent (undetected), or it can be a catastrophic occurrence with (...)
• 01:00
  Unraveling the invisible demon: a study of the oxidative stress markers, antioxidant activities and inflammatory markers in patients admitted with complete heart block Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionDespite the recent advancements in the management of Complete Heart Block (CHB), the aetiology of CHB is still idiopathic in most of the cases. Our study explores this hitherto untouched aspect of complete heart (...)
• 01:00
  Amplatzer amulet versus watchman device for percutaneous left atrial appendage closure: a systematic review and meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundThe Amplatzer Amulet and Watchman devices are the two most frequently used devices for percutaneous LAA closure globally.AimTo evaluate the safety and clinical outcomes associated with these two devices in patients (...)
• 01:00
  Relationship and outcomes between volume status, cardiac and renal dysfunction in patients with chronic heart failure Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundRight heart and renal dysfunction occurring due to volume fluid redistribution remain a front-line issue in the development of the syndrome of congestion in chronic heart failure (HF). Quantitative total blood volume (TBV) (...)
• 01:00
  HbA1c variability is associated with adverse outcomes in heart failure patients with and without diabetes Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundGlycemic control is an important clinical issue in the management of patients with heart failure (HF). Variability of Glycated hemoglobin A1c (HbA1c) has been proven to be a predictor of cardiovascular events. However, (...)
• 01:00
  Accuracy in precise DAPT score compared with CRUSADE score in Thai population Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public hospital(s). Main funding source(s): Rajavithi hospitalIntroductionMyocardial infarction is one of the most common cardiovascular disease in the world including Thai population. The current treatment strategy is percutaneous (...)
• 01:00
  Predictors of angiographically normal coronary arteries Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionCoronary angiography (CAG) has been recommended for patients with well-established risk factors. However, striking rates of coronary angiograms were turning out to be normal and very little is known regarding the (...)
• 01:00
  Investigating factors associated with the prevalence of IHD among uncontrolled diabetic patients Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Other. Main funding source(s): Monash University MalaysiaBackgroundIschaemic Heart Disease (IHD) is the leading cause of death in Malaysia (1), and there is an increasing trend in mortality due to IHD from 15.2% in 2019 to 17.2% in 2020 (...)
• 01:00
  Increased level of plasma Cyclophilin A in early diabetic population suggesting it as a reliable pro inflammatory biomarker of coronary artery disease in diabetic patients Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Other. Main funding source(s): Institute of Cardiovascular disease, Madras Medical MissionBackgroundType 2 Diabetes (DM) is a pro-inflammatory state in the pathogenesis of Atherosclerosis with the presence of many active proteins, of (...)
• 01:00
  Differential expression of TLR4 in patients of coronary artery disease with and without traditional cardiovascular risk factors Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundAtherosclerosis is inherently an inflammatory process, with a complex interplay of inflammatory markers. It is established that these inflammatory markers play an important role in patients of Coronary Artery Disease(CAD) (...)
• 01:00
  Higher risk of adverse cardiovascular outcomes in women with type 2 diabetes mellitus: an umbrella review of systematic reviews Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundPrevious studies have shown that females with type 2 diabetes mellitus (T2DM) may have an excess mortality risk compared to males. Furthermore, other studies have reported sex differences in managing cardiovascular risk (...)
• 01:00
  Perceptions, insights, and attitudes (P.I.A.) of selected filipino female physicians on cardiovascular risks and diseases Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionIn 2012, coronary heart disease and stroke are the leading causes of death worldwide, accounting for more than 31% of deaths from all causes. In 2020, PH statistics showed that ischemic heart diseases were the leading (...)
• 01:00
  Cardiac rehabilitation results among patients who have undergone cardiac surgery after covid-19 infection Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundCoronavirus disease 2019 (Covid-19) has become a global pandemic. Covid-19 increases morbidity in patients with underlying cardiovascular disease. The six-minute walk test (6MWT) is a simple test for assessing (...)
• 01:00
  The impact of diabetes mellitus on improvement of resting rate pressure product in patients with refractory angina undergone external counter pulsation Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundThe management of coronary artery disease (CAD) has developed significantly in the last few decades. One of the therapeutic modalities that could be considered to patients with refractory angina caused by CAD is external (...)
• 01:00
  Real-world comparison of intracoronary imaging and fractional flow reserve measurements on outcomes of semi-urgent and elective percutaneous coronary intervention in a multi-ethnic asian population Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundIntracoronary imaging and fractional flow reserve measurements (FFR) are helpful in optimisation of percutaneous coronary intervention (PCI) for patients with stable coronary artery disease, but their comparative efficacy (...)
• 01:00
  A meta-analysis on the efficacy of influenza vaccine in reducing cardiovascular mortality and myocardial infarction in patients with cardiovascular disease Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionInfluenza infection has been linked to adverse cardiovascular events in coronary artery disease (CAD) patients. Despite the compelling link between influenza vaccine’s protective potential in observational studies, the (...)
• 01:00
  Correlation of Echoradiography Pulmonary to Left Atrial Ratio (ePLAR) with Right Heart Catheterization Parameters in Pulmonal Arterial Hypertension Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundUntil now, right heart catheterization is still the gold standard for pulmonary hypertension examination, but this examination is invasive, has a risk of action, and is limited. Echocardiography provides an alternative (...)
• 01:00
  The effect of ras human orthologue kinase inhibitor on the treatment of pulmonary hypertension: a systematic review Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundPulmonary hypertension (PH) is a high mortality and an uncrackable disease up to date. The complex pathophysiology is one of the reasons for only a view treatment that can be given to patients with PH. Recent studies have (...)
• 01:00
  Efficacy of home-based versus centre-based cardiac rehabilitation in an Indian cardiovascular disease population Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundCardiac rehabilitation (CR), an integral component of cardiovascular disease (CVD) management in developed countries, is yet to become mainstream in India. With the prevailing gross mismatch between the need and the (...)
• 01:00
  Prevalence of cardiovascular disease and thromboembolic events in a prospective cohort of patients with sickle cell disease Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionSickle cell disease (SCD) is an inherited disorder of globin chains that cause haemolysis, thrombosis and chronic organ damage. SCD affects multiple organs including the cardiovascular system. The two main subtypes of SCD (...)
• 01:00
  Prevalence of cardiovascular disease in Sickle cell disease (SCD)- An echocardiographic and pharmacological analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionSickle cell disease (SCD) is an inherited disorder of globin chains that cause haemolysis and chronic organ damage. It is an autosomal recessive condition. SCD is a condition more prevalent in sub-saharan Africa. It is (...)
• 01:00
  Predictors of outcomes of acute coronary syndrome in women admitted in the coronary care unit, cardiovascular unit and medical ICU of a tertiary hospital from January 2015 to December 2020 Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundAcute Coronary Syndrome (ACS) is a leading cause of demise in the Asia-Pacific region. Women, especially those more than 65 years old, do not seek treatment immediately because symptoms are usually atypical. A study done in (...)
• 01:00
  Myocardial bridge over coronary arteries and myocardial coat over coronary sinus: a cadaveric study Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundMyocardial Bridge (MB) over the coronary artery and myocardial coat (MC) over the cardiac veins are sometimes detected in angiography and cadaveric dissection. Left anterior descending (LAD) branch of left coronary artery (...)
• 01:00
  Secreted APE1/Ref-1 inhibits doxorubicin-induced cardiotoxicity via suppressing ROS generation and p53 pathway Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public grant(s) – National budget only. Main funding source(s): This research is supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of (...)
• 01:00
  S-Allylcysteine limits cardiac structural changes via antioxidant status in ovariectomized rats with induced myocardial injury Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public grant(s) – National budget only. Main funding source(s): Ministry of Higher Education, Malaysia (Fundamental Research Grant Scheme)BackgroundCardiovascular disease is the primary cause of death in Malaysia. Past studies have shown (...)
• 01:00
  Cardiovascular Profile of patients with COVID-19 infection admitted at a tertiary hospital Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionIn December 2019, a novel Coronavirus disease 2019 (COVID-19) was discovered and spread rapidly worldwide. The virus spared no country in its contagiousness. The most common clinical manifestations are respiratory (...)
• 01:00
  Incidence of myocarditis among patients recovered from COVID-19 infection identified using cardiac magnetic resonance imaging Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionCoronavirus disease 2019 (COVID-19) has caused significant morbidity and mortality worldwide and has been associated with several cardiac complications including myocarditis. COVID-19 patients with myocardial injury have (...)
• 01:00
  Association of left atrial ejection fraction and cardiovascular outcomes in Asian patients with hypertrophic cardiomyopathy Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public Institution(s). Main funding source(s): National University of Singapore Yong Loo Lin School of Medicine's Junior Academic Fellowship SchemeBackgroundThe optimal method of risk stratification of hyp­ertrophic cardiomyopathy (HCM) (...)
• 01:00
  Multicenter registry of the Watchman left atrial appendage closure device for patients with atrial fibrillation in Japan: The TERMINATOR registry Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): Boston Scientific JapanBackgroundTranscatheter left atrial appendage closure (LAAC) provides an alternative to oral anticoagulation for thromboembolic risk reduction in patients (...)
• 01:00
  An updated meta-analysis: The effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the mortality of hypertensive patients with confirmed COVID-19 infection Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundOne of the most common co-morbidities identified among COVID-19 patients was hypertension. Debates on use of Angiotensin-Converting Enzyme Inhibitors (ACEI) and Angiotensin-Receptor blockers (ARB) emerged due to an (...)
• 01:00
  Understanding the management of hypertension in Asia: results of a literature search Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Private company. Main funding source(s): Servier, FranceBackgroundHypertension poses a significant healthcare burden in Asia. Detection, treatment and control of hypertension are suboptimal, despite the existence of clear international (...)
• 01:00
  Comparison of risk of hyperkalemia between SGLT2 inhibitors and DPP4-inhibitors in patients with type 2 diabetes Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundHyperkalemia is a common complication and increases the risk of cardiac arrhythmias and mortality in patients with type 2 diabetes (T2DM), especially in those with diabetic nephropathy. We investigated the risk of (...)
• 01:00
  The use of ticagrelor versus clopidogrel in Malaysian patients with coronary artery disease undergoing percutaneous coronary intervention (PCI): Does the age tertile affect the platelet reactivity? Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundPrevious studies have shown that the prevalence of cardiovascular diseases is related to the patient's age and gender differences, but the effect of age on platelet function remains controversial. Platelet function should (...)
• 01:00
  Effects of epicardial adipose tissue volume and thickness assessed by computed tomography and echocardiography on cardiovascular and cerebrovascular outcomes: a systematic review and meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundEpicardial adipose tissue (EAT) has garnered attention as a potential imaging biomarker for the risk stratification of cardiovascular diseases (CVD). However, the prognostic utility of EAT due to inter-ethnic differences (...)
• 01:00
  Pathophysiologic mechanism for MYOcarditis in COVID-19 VAccinations ("MYOVAx" Study) Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public grant(s) – National budget only. Main funding source(s): NMRC COVID-19 Research FundObjectiveThis is the first prospective cohort study in Singapore to investigate the COVID-19 vaccine-associated myocarditis to understand its (...)
• 01:00
  Ambient heat exposure after the rainy season is associated with an increased risk of Stroke Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundStroke is a major global health issue and Climate change is the biggest and most urgent challenges. The Asia and Pacific region have been more vulnerable to climate change and extreme heat exposure than other regions of the (...)
• 01:00
  Improving cardiovascular health behaviors through a comprehensive lifestyle intervention program during the pandemic in India Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundWe have witnessed a dramatic dip in adherence to cardiovascular health behaviors during the COVID-19 pandemic. Data from across the globe has shown that risk factors for cardiovascular disease (CVD) such as decreased (...)
• 01:00
  Association between non-alcoholic fatty liver disease and incidence of arrhythmia and other cardiovascular outcomes: a systematic review and meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundThe association between non-alcoholic fatty liver disease (NAFLD) with cardiovascular and cerebrovascular outcomes, as well as their clinical impact, has yet to be established in the literature.ObjectiveWe aim to evaluate (...)
• 01:00
  Incident heart failure and the subsequent risk for progression to end stage kidney disease in South East Asian people with type 2 diabetes Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public grant(s) – National budget only. Main funding source(s): Singapore National Medical Research Council grants: CSA-INV/0020/2017 and CS-IRG (MOH-000066)BackgroundHeart failure (HF) is a common but often unrecognized complication of (...)
• 01:00
  Gender distribution in STEMI patients and how does it affect primary PCI performances Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Private hospital(s). Main funding source(s): Jakarta Heart CenterBackgroundManaging ST-Segment Elevation Myocardial Infarction (STEMI) patients was always challenging for Healthcare Professionals (HCP) to pursue time-sensitive treatment.1 (...)
• 01:00
  Association between body mass index (BMI) and severity of coronary artery disease in young onset acute coronary syndrome (ACS) Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundA high body mass index (BMI) is seems to be associated with an increased incidence of coronary artery disease. If the affected person is young, the consequences are more tragic. There are variable information on the (...)
• 01:00
  Multicenter review of a tadalafil suspension formulation in infants and children with pulmonary hypertension: a north american experience Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundPulmonary arterial hypertension (PAH) is a disease characterised by an increase in pulmonary vascular resistance and pulmonary artery pressure. Phosphodiesterase type 5 (PDE5) inhibitors, with sildenafil the earliest among (...)
• 01:00
  Preliminary findings from a risk stratification, quality of life and burden of illness in pulmonary arterial hypertension pilot study Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): Janssen Australia and New Zealand (Janssen-Cilag Pty Ltd)Pulmonary Arterial Hypertension (PAH) management strategies focus on lowering mortality risk, extending the patient’s (...)
• 01:00
  Optical Coherence Tomography (OCT) evaluation of culprit lesions in patients with Non-ST Elevation Acute Coronary Syndromes (NSTE-ACS) Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundOCT is an excellent tool to determine plaque morphology in Acute Coronary Syndromes. While plaque rupture has been determined to be the dominant morphology in ST Elevation Myocardial Infarction, there is paucity of (...)
• 01:00
  Angiography alone versus angiography plus intracoronary imaging to guide emergency percutaneous coronary intervention: outcomes from a single-centre retrospective analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundThere is emerging evidence showing improvement in clinical outcomes with optical coherence tomography (OCT) and intravascular ultrasound (IVUS)-guided elective percutaneous coronary intervention (PCI). Yet data supporting (...)
• 01:00
  Prioritization of invasive coronary angiogram for deserving patients with chronic coronary syndrome (CCS) using an Angiogram Eligibility Scoring (AES) system - A Clinical Audit Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionMany patients with CCS are usually referred for invasive treatment early on first come first serve basis. Proper clinical assessment of the severity of symptoms and optimization of the medical therapy lack before referral (...)
• 01:00
  Modified STEMI protocol for Primary PCI during COVID-19 Pandemic:Does it prolong Door-To-Balloon performance? Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Private hospital(s). Main funding source(s): Jakarta Heart CenterBackgroundCOVID-19 became a main health problem and causes heavy impact, especially for healthcare system. Managing ST-Segment Elevation Myocardial Infarction (STEMI) (...)
• 01:00
  Perindopril Reduce SARS-COV-2 Spike-ACE2 Binding, ACE2 Overexpression and Cytokine Storm in Adipocyte Cell Infected with SARS-COV-2 Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public Institution(s). Main funding source(s): RistekdiktiBackground and AimsThe SARS-CoV-2 virus can infect adipocyte cells via ACE2 Receptor thus triggering ACE2 overexpression and cytokine storms which cause lethal complications. (...)
• 01:00
  Antithrombotics prescription pattern and clinical outcomes in atrial fibrillation patients with type 2 diabetes mellitus Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundAtrial fibrillation (AF) and Diabetes mellitus (DM) often coexist. As DM is considered while calculating the thromboembolic risk for AF patients, little is known about the prescription pattern of antithrombotic therapies in (...)
• 01:00
  Effect of therapeutic dose anticoagulation vs prophylactic dose anticoagulation in reducing venous thromboembolism, arterial thrombosis or death events among hospitalized non-critically ill COVID19 pt Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.TitleThe Effect of Therapeutic Dose Anticoagulation Versus Prophylactic Dose Anticoagulation in Reducing Venous Thromboembolism (VTE), Arterial Thrombosis (ATE) or Death Events Among Hospitalized Non-critically Ill COVID-19 Patients: (...)
• 01:00
  Platelet reactivity index after treatment of clopidogrel versus ticagrelor based on CYP2C19 genotypes among patients undergoing percutaneous coronary intervention: results of a randomized study Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundAlthough clopidogrel is the basic drug for antiplatelet therapy in patients with coronary artery disease (CAD). However, loss of function (LOF) allelic variants located within the CYP2C19 gene may reduce the production of (...)
• 01:00
  Concurrent left ventricular myocardial diffuse fibrosis and left atrial dysfunction strongly predicts incident heart failure and all-cause mortality Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Foundation. Main funding source(s): British Heart FoundationAcademy of Medical SciencesBackgroundLV myocardial interstitial fibrosis has been reported to influence LA morphology and function via LV remodelling and diastolic dysfunction. (...)
• 01:00
  Comparison of his bundle pacing versus biventricular pacing in heart failure: a systematic review and meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionDespite optimal medical treatment, the 5-years mortality and HF readmission rate was 75.3% and 48.5%, respectively. The current guidelines recommended cardiac resynchronization therapy (CRT) by implanting biventricular (...)
• 01:00
  Sex difference in neurological outcome and post-cardiac arrest care in out-of-hospital cardiac arrest patients treated with targeted temperature management Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.ObjectivesConflicting results regarding sex-based differences in the outcomes of out-of-hospital cardiac arrest (OHCA) patients have been reported. Furthermore, no study has examined whether differences in in-hospital interventions (...)
• 01:00
  Real-world outcomes of Selexipag for treatment of pulmonary hypertension in an Asian population Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionSelexipag is an oral selective prostacyclin IP receptor agonist indicated for treatment of pulmonary arterial hypertension (PAH). Data on its real-world safety and efficacy in Asians is lacking.PurposeWe sought to (...)
• 01:00
  A canadian retrospective multicenter experience with selexipag in a heterogeneous group of pediatric pulmonary hypertension patients Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundThe introduction of the oral prostanoid selexipag for treating severe adult pulmonary arterial hypertension (PH) has contributed to reduced rates of death and secondary complications in PAH. Pediatric physicians have (...)
• 01:00
  Global burden of metabolic diseases: data from Global Burden of Disease 2000-2019. A cosortium of metabolic disease Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundThe growing prevalence of metabolic diseases is a major concern. We sought to examine the global trends and mortality of metabolic diseases using estimates from the Global Burden of Diseases, Injuries and Risk Factors Study (...)
• 01:00
  Geographic areas of responsibility among PCI-capable hospitals in the Philippines Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionThe archipelagic nature of the Philippines is unique and the geographic areas of responsibility for ST elevation myocardial infarction patients should be defined.MethodologyThe list of registered PCI capable hospitals and (...)
• 01:00
  Change in minimum indexed left atrial volume predicts incident heart failure: the multi-ethnic study of atherosclerosis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Background and PurposeLongitudinal change in the left atrium prior to the onset of heart failure has not been as well studied as left atrial (LA) dysfunction in pre-existing heart failure. This study used cardiac magnetic resonance (...)
• 01:00
  Characteristics and outcomes of patients presenting with out of hospital cardiac arrest to a regional hospital Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionOut of hospital cardiac arrest (OHCA) carries a high rate of mortality and can be due to cardiac or non-cardiac causes. We reviewed consecutive patients presenting with OHCA to the emergency department of a regional (...)
• 01:00
  Vaccination status and knowledge of CPR do not affect medical students' decision to perform BLS during the COVID-19 pandemic Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionTo address the risks of transmission by COVID-19, various recommendations been released by medical societies, which include strongly advocating for the use of personal protective equipment. In addition, hands-only (...)
• 01:00
  Sex-based comparisons of clinical characteristics and outcomes of patients with embolic stroke of undetermined source with implantable loop recorders Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionEmbolic strokes of undetermined source (ESUS) constitute a significant proportion of all ischemic strokes, but sex-based comparisons of clinical characteristics and outcomes of ESUS patients have not been well explored. (...)
• 01:00
  Arterial thromboembolism (ATE) and mortality among COVID-19 patients in the intensive care unit (ICU): prevalence and risk factors Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.ObjectiveTo investigate the prevalence of arterial thromboembolic (TE) complications including stroke, peripheral arterial disease (PAD) and myocardial infarction (MI) and mortality among COVID-19 patients admitted to an ICU at a (...)
• 01:00
  Predictors of left ventricular mass and coronary artery calcium phenotypes Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public Institution(s). Main funding source(s): National Medical Research Council, Ministry of Health, Singapore and the Lee FoundationBackgroundLeft ventricular (LV) mass and coronary artery calcium score (CACS) are both independent (...)
• 01:00
  LDL cholesterol an unmet target in diabetic, hypertensive population pan India exposing susceptive cardiovascular disorder risk Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundManagement and pathophysiology of diabetes and hypertension has always been the centre of research, with new insights being found consistently. CVD is the major cause of mortality in patients with type 2 diabetes and (...)
• 01:00
  Demographic, clinical, and echocardiographic factors predicting maintenance of sinus rhythm following first elective cardioversion Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Background/IntroductionAtrial fibrillation is common. Cardioversion to restore sinus rhythm is successful in over 90% of cases, but reversion to atrial fibrillation within a year occurs in the majority. Although predictors of (...)
• 01:00
  Catheter ablation vs medical therapy for treatment of atrial fibrillation patients with heart failure with preserved ejection fraction: a systematic review and meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionCatheter ablation (CA) is used as a treatment option in selected patients with atrial fibrillation (AF) and heart failure with reduced ejection fraction (HFrEF) as studies have shown that it reduces heart failure (HF) (...)
• 01:00
  The efficacy and safety of pulsed-field ablation in para-Hisian paroxysmal supraventricular tachycardia: first-in-human pilot trial Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public Institution(s). Main funding source(s): National Key Research and Development Program of ChinaBackgroundPara-Hisian paroxysmal supraventricular tachycardia (PSVT) is associated with a higher risk of atrioventricular block due to (...)
• 01:00
  Pregnancy in patients with complete atrioventricular block: management and perinatal outcomes Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundAlthough bradyarrhythmias may occur in pregnant patients, there are few data on their management, pregnancy course and perinatal outcomes.PurposeTo evaluate the effects of bradyarrhythmias on the course and outcomes of (...)
• 01:00
  Voltage/mass ratio (VMR) prognosis value in heart failure (HF) patients with transthyretin cardiac amyloidosis (ATTR-CA) Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionTransthyretin cardiac amyloidosis (ATTR-CA) is an emerging cause of heart failure (HF) and is associated with cardiac mass hypertrophy and voltage impairment, but little is known on how theses markers interplay with (...)
• 01:00
  A retrospective study of characteristics and burden of heart failure in Thailand: an interim analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Private company. Main funding source(s): Novartis (Thailand) LimitedBackground/IntroductionHeart failure (HF) is a major health problem due to its significant prevalence, disease burden and cost, mainly driven by high rates of (...)
• 01:00
  Efficacy and safety of sacubitril/valsartan in patients with acute decompensated heart failure: a systematic review and meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionSacubitril/Valsartan is the cornerstone in the treatment of heart failure with reduced ejection fraction (HFrEF). However, there is limited data on their risk-benefit in patients with acute heart failure requiring (...)

21 January

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  The Journal Citation Indicator: what is the relevance of this new metric? Eur Heart J
  For years, the scientific community has been searching for an optimal way to measure and understand the engagement and impact of scientific publications. The impact factor (IF), which is released annually by Clarivate Analytics in the Journal Citation Reports (JCR), is by far the most utilised (...)
• 01:00
  Ischaemic heart disease: antithrombotic treatment and new therapeutic targets Eur Heart J

14 January

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Management of atrial fibrillation: role of population screening, biomarkers, and polygenic risk scores Eur Heart J

7 January

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Hot topics in ischaemic heart disease: polygenic risk scores, coronary microvascular dysfunction, myocardial injury, and diagnostic role of imaging Eur Heart J

2 January

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  The year in cardiovascular medicine 2022: the top 10 papers in interventional cardiology Eur Heart J
• 01:00
  The year in cardiovascular medicine 2022: the top 10 papers in dyslipidaemias Eur Heart J

1 January

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Acute and chronic heart failure: exciting therapeutic perspectives Eur Heart J

21 December

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Focus on trials: dementia, lipids, thrombosis, and heart failure Eur Heart J

14 December

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Vinculin phosphorylation modulates endothelial cell permeability: a new target for cardiovascular disease? Eur Heart J

7 December

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Acute, periprocedural and longterm antithrombotic therapy in older adults2022 Update by the ESC Working Group on Thrombosis Eur Heart J
  AbstractThe first international guidance on antithrombotic therapy in the elderly came from the European Society of Cardiology Working Group on Thrombosis in 2015. This same group has updated its previous report on antiplatelet and anticoagulant drugs for older patients with acute or chronic (...)
• 01:00
  Hypertrophic cardiomyopathy and left ventricular non-compaction cardiomyopathy: two in one Eur Heart J
  A 22-year-old asymptomatic Caucasian woman was referred because of an elevated NT-pro-BNP level (1225 ng/L, normal Panel A). The transthoracic echocardiography revealed an asymmetrical LV hypertrophy without signs of left ventricular outflow tract obstruction at rest or under provocative (...)
• 01:00
  Coronary interventions 2021: insights from the National Societies of Cardiology Journals of the European Society of Cardiology Eur Heart J
  Several challenging issues with regards to the very large amount of percutaneous coronary interventions (PCIs) performed and the numerous clinical settings they apply have been addressed by studies published in National Societies of Cardiology Journals (...)
• 01:00
  The ‘10 commandments’ for the 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac deathThe 2022 ESC Guidelines for the management of patients with ventricular arrhythmias (VAs) and the prevention of sudden cardiac death (SCD) present an update of the 2015 guidelines. Eur Heart J
  Important points to remember (the ‘10 commandments’):
• 01:00
  Polygenic risk scores for the prediction of cardiometabolic disease Eur Heart J
  AbstractCardiometabolic diseases contribute more to global morbidity and mortality than any other group of disorders. Polygenic risk scores (PRSs), the weighted summation of individually small-effect genetic variants, represent an advance in our ability to predict the development and (...)

2 December

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Growth differentiation factor 15: a biomarker searching for an indication Eur Heart J
• 01:00
  Screening for atrial fibrillation to prevent stroke: increasing enthusiasm but outcomes still lag Eur Heart J
• 01:00
  Cardiac tamponade caused by intrapericardial diaphragmatic hernia Eur Heart J
• 01:00
  Guideline-based use of cardiac imaging for chronic coronary syndromes Eur Heart J

1 December

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Protection and delay of aortic complications in the Marfan syndrome: a new indication for angiotensin receptor blockers on top of ? blockers Eur Heart J
  Comment on ‘Angiotensin receptor blockers and ? blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials’ which was published in the Lancet; https://doi.org/10.1016/S0140-6736(22)01534-3.
• 01:00
  Erratum to: Moderate intensity continuous and high intensity interval training as strategy cardioprotective on cardiotoxicity induced by cancer. Randomized clinical trial Eur Heart J
  This is an erratum to: J A Lara Vargas, J E Pereira-Rodriguez, D G Penaranda Florez, G Galdino, G Xavier-Santos, P Pereira-Rodriguez, R Pereira-Rodriguez, F Ceballo-Portilla, M Diaz-Bravo, Moderate intensity continuous and high intensity interval training as strategy cardioprotective on (...)
• 01:00
  Use of cardiac imaging in chronic coronary syndromes: the EURECA Imaging registry Eur Heart J
  AbstractBackgroundThe prospective, multicentre EURECA registry assessed the use of imaging and adoption of the European Society of Cardiology (ESC) Guidelines (GL) in patients with chronic coronary syndromes (CCS).MethodsBetween May 2019 and March 2020, 5156 patients were recruited in 73 (...)

28 November

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Erratum to: Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis Eur Heart J
  This is an erratum to: Mihir A Kelshiker, Henry Seligman, James P Howard, Haseeb Rahman, Michael Foley, Alexandra N Nowbar, Christopher A Rajkumar, Matthew J Shun-Shin, Yousif Ahmad, Sayan Sen, Rasha Al-Lamee, Ricardo Petraco, the Coronary Flow Outcomes Reviewing Committee, Coronary flow (...)

26 November

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Half a century of experience with congenital heart disease: what have we learned about ventricular septal defects? Eur Heart J
  This editorial refers to ‘Survival of patients with congenital ventricular septal defect’, by F. Eckerström et al., https://doi.org/10.1093/eurheartj/ehac618.

25 November

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Accidental coronary artery kinking by leadless pacemaker fixation tine Eur Heart J
  French GovernmentNational Research Agency
• 01:00
  Assessing and treating congestion in acute decompensated heart failure: are we seeing the light at the end of the tunnel? Eur Heart J

24 November

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  First-in-human transcatheter endocardial alginate-hydrogel implantation for the treatment of heart failure Eur Heart J
• 01:00
  Meet Habib Gamra: new European Heart Journal co-editor for North Africa Eur Heart J
  Habib Gamra, MD, became the new co-editor for North Africa in September 2022. He shared some of his plans for the role with CardioPulse ( Figure 1).
• 01:00
  Preprints: a game changer in scientific publications? Eur Heart J
  The landscape of scientific publications has always been a moving field. Dissemination of medical and scientific information has been boosted in the digital era with the advent of Internet which has won the race for priority and exclusivity to traditional journals. Recently, preprints have (...)
• 01:00
  Shocking insights on resuscitation after sports-related cardiac arrest Eur Heart J
• 01:00
  The ‘Ten Commandments’ for the 2022 European Society of Cardiology guidelines on cardio-oncology Eur Heart J
  The 2022 European Society of Cardiology (ESC) guidelines on cardio-oncology1 advise cardiologists, oncologists, and haematologists how to manage patients with cancer who may be at risk of cancer therapy-related cardiovascular toxicity (...)
• 01:00
  Survival of patients with congenital ventricular septal defect Eur Heart J
  AbstractAimsThe long-term survival of patients with isolated congenital ventricular septal defect (VSD) is not well described. The aim of this study was to describe the survival of a national cohort of patients with VSD compared with the general population.Methods and resultsUsing Danish (...)

22 November

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  First in man: sealing the distal re-entry tears of aortic dissection after thoracic endovascular aortic repair by an ENDOPATCH™ system Eur Heart J
  National Key Research and Development10.13039/501100012166

18 November

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  A specific new biomarker for atrial fibrillation and its sequelae? Eur Heart J

16 November

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Young at heart: a DNA methylation's tale Eur Heart J
  Aging is an incessant and unavoidable process that affects all organisms from birth to death. However, behavioural and economic conditions, lifestyle, diet, and physical activity, as well as genetic and epigenetic variables, play a pivotal role in its progression. Several strategies have been (...)
• 01:00
  Vinculin phosphorylation impairs vascular endothelial junctions promoting atherosclerosis Eur Heart J
  AbstractBackground and aimsAtherosclerosis preferentially develops in arterial branches and curvatures where vascular endothelium is exposed to disturbed flow. In this study, the effects of disturbed flow on the regulation of vascular endothelial phosphoproteins and their contribution to (...)
• 01:00
  Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation Eur Heart J
  AbstractAimsBiomarkers specifically related to atrial tissue may increase the understanding of the pathophysiology of atrial fibrillation (AF) and further improve risk prediction in this setting. Bone morphogenetic protein 10 (BMP10) is a protein expressed in the atrial myocardium. We evaluated (...)
• 01:00
  Meet the new European Society of Cardiology Board 2022–2024 Eur Heart J
  The ESC is governed by an elected board of cardiology experts supported by officials and managed by a chief executive officer who reports to the President and Management Group of the ESC Board. CardioPulse presents the new 2022–2024 Board (Figure (...)

15 November

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome Eur Heart J
  This commentary refers to ‘Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial’, by J.C. Tardif et al., https://doi.org/10.1093/eurheartj/ehac374 and the discussion piece ‘dal-GenE was negative—not positive except for COVID-19’, by A.D. Sniderman, (...)
• 01:00
  dal-GenE was negative—not positive except for COVID-19 Eur Heart J
  This commentary refers to ‘Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial’, by J. C. Tardif et al.,https://doi.org/10.1093/eurheartj/ehac374 and the discussion piece ‘Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome’, by (...)

12 November

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Benefits of SGLT2i in heart failure across a broad range of ejection fractions: new opportunities and future challenges Eur Heart J
  Comment on ‘SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomized controlled trials’ which was published in the New England Journal of Medicine, https://doi.org/10.1016/S0140-6736(22)01429-5.
• 01:00
  A broader perspective on autoimmune diseases and cardiovascular risk Eur Heart J
  Comment on the article ‘Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK.’ published in Lancet; https://doi.org/10.1016/S0140-6736(22)01349-6.
• 01:00
  Incidental detection in the DANCAVAS trial was limited by design and did not bias the cost effectiveness conclusion Eur Heart J
  This commentary refers to ‘Cost effectiveness of population screening versus no screening for cardiovascular disease: the Danish Cardiovascular Screening trial (DANCAVAS)’, by R. Søgaard et al., https://doi.org/10.1093/eurheartj/ehac488 and the discussion piece ‘More costs than benefits from (...)
• 01:00
  More costs than benefits from screening for cardiovascular disease with computed tomography in the DANCAVAS study Eur Heart J
  This commentary refers to ‘Cost effectiveness of population screening versus no screening for cardiovascular disease: the Danish Cardiovascular Screening trial (DANCAVAS)', by R. Søgaard et al., https://doi.org/10.1093/eurheartj/ehac488 and the discussion piece ‘Incidental detection in the (...)
• 01:00
  Fit for the future: empowering clinical trials with digital technology Eur Heart J
• 01:00
  Growing giant coronary artery aneurysm Eur Heart J

11 November

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Evolving landscapes driving cardiovascular diseases require a Circular Health approach Eur Heart J
  Cardiovascular diseases (CVDs) are still the leading cause of mortality in Western countries. Advancements in diagnosis, therapy, and prevention between 1900 and 1999, particularly after World War 2, improved clinical outcomes of CVD treatments, both on individuals and on society in general.1 (...)
• 01:00
  Heart and brain interactions: is small vessel disease a link? Eur Heart J
• 01:00
  Omecamtiv mecarbil for patients with severe systolic dysfunction and hypotension Eur Heart J
• 01:00
  Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54 Eur Heart J
  AbstractAimIn patients with prior myocardial infarction (MI) on aspirin, the addition of ticagrelor reduces ischaemic risk but increases bleeding risk. The simultaneous assessment of baseline ischaemic and bleeding risk may assist clinicians in selecting patients who are most likely to have a (...)
• 01:00
  Platelet antiaggregation after an acute coronary syndrome: what about the elderly? Eur Heart J

9 November

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study Eur Heart J
  AbstractAimsPrevious studies on the cost-effectiveness of screening for atrial fibrillation (AF) are based on assumptions of long-term clinical effects. The STROKESTOP study, which randomised 27 975 persons aged 75/76 years into a screening invitation group and a control group, has a median (...)

7 November

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Coronary microvascular dysfunction is associated with impaired cognitive function: the Cerebral-Coronary Connection study (C3 study) Eur Heart J
  AbstractBackgroundIt remains unknown whether the presence of coronary microcirculatory dysfunction (CMD) correlates with its equivalent condition in the brain, cerebral small vessel disease (CSVD). The cerebral-coronary connection (C3), a prospective blinded study, investigated the prevalence (...)
• 01:00
  Cardiac troponin release following coronary artery bypass grafting: mechanisms and clinical implications Eur Heart J
  AbstractThe use of biomarkers is undisputed in the diagnosis of primary myocardial infarction (MI), but their value for identifying MI is less well studied in the postoperative phase following coronary artery bypass grafting (CABG). To identify patients with periprocedural MI (PMI), several (...)
• 01:00
  Solid evidence that very few muscle symptoms are due to statin therapy Eur Heart J
  Comment on the article ‘Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials’, presented at the European Society of Cardiology Congress 2022 and simultaneously published in the (...)
• 01:00
  SGLT2 inhibitors in heart failure: insights from plasma proteomics Eur Heart J

5 November

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Erratum to: Sutton’s law and dietary Na+/K+ intake in cardiovascular disease Eur Heart J
  This is an erratum to: Franz H Messerli, Maria Lorenza Muiesan, Adrian W Messerli, Sutton’s law and dietary Na+/K+ intake in cardiovascular disease, European Heart Journal, Volume 43, Issue 30, 7 August 2022, Pages 2876–2877, https://doi.org/10.1093/eurheartj/ehac283.

4 November

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  In conversation with Alexandros Protonotarios Eur Heart J
  Alex Protonotarios was born and raised in Greece on the cyclidic island of Naxos. Both his parents were doctors and active researchers who instilled a sense of inspiration in him that propelled him to study medicine. He received his medical degree from the University of Crete, Greece, before (...)
• 01:00
  Cholesterol lowering with inclisiran: a new chapter in the PCSK9 story book Eur Heart J
• 01:00
  Inclisiran and cardiovascular events: a patient-level analysis of phase III trials Eur Heart J
  AbstractBackgroundInclisiran, an siRNA administered twice-yearly, significantly reduced LDL cholesterol (LDL-C) in Phase III trials. Whether lowering LDL-C with inclisiran translates into a lower risk of cardiovascular (CV) events is not yet established.Methods and resultsPatient-level, pooled (...)
• 01:00
  Inclisiran in primary prevention: reality or fiction? Eur Heart J
• 01:00
  Effect of inclisiran on lipids in primary prevention: the ORION-11 trial Eur Heart J
  AbstractAimsPatients often require combination therapies to achieve LDL cholesterol (LDL-C) targets for the primary prevention of atherosclerotic cardiovascular disease. This study investigates the effect of inclisiran, a small interfering ribonucleic acid targeting hepatic proprotein (...)

28 October

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis Eur Heart J
  AbstractAimsLevels of growth differentiation factor 15 (GDF-15), a cytokine secreted in response to cellular stress and inflammation, have been associated with multiple types of cardiovascular (CV) events. However, its comparative prognostic performance across different presentations of (...)
• 02:00
  Oral P2Y12 inhibiting therapy in patients with acute coronary syndrome: finding the sweet spot Eur Heart J
  This commentary refers to ‘Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials’, by M. Galli et al., https://doi.org/10.1093/eurheartj/ehab836 and the discussion piece ‘Are there other (...)
• 02:00
  Are there other factors that influence the assessment of bleeding risk comparing potent P2Y12 inhibitors with clopidogrel? Eur Heart J
  This commentary refers to ‘Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials’, by M. Galli et al., https://doi.org/10.1093/eurheartj/ehab836 and the discussion piece ‘Oral P2Y12 (...)
• 02:00
  Interview with Nobel Laureate Gregg Semenza: an inspiring story for young researchers Eur Heart J
  Gregg Semenza, MD, PhD is professor of Genetic Medicine at the Johns Hopkins School of Medicine, in the United States. He is known for his discovery of hypoxia-inducible factor 1 (HIF-1), which allows cells to adapt to oxygen-poor environments. He shared the 2019 Nobel Prize in Physiology or (...)

27 October

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Virtual hospitals and digital doctors: how far are we from the CardioVerse? Eur Heart J
  Digital health and telemedicine flourished during the recent pandemic and modified the traditional physical way of patient–doctor interaction by using digital means and internet. While technology has become integral to cardiovascular medicine and augmented and virtual reality (AR/VR) are (...)

26 October

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Association between basic life support and survival in sports-related sudden cardiac arrest: a meta-analysis Eur Heart J
  AbstractAimsTo evaluate the association of basic life support with survival after sports-related sudden cardiac arrest (SR-SCA).Methods and resultsIn this systematic review and meta-analysis, a search of several databases from each database inception to 31 July 2021 without language (...)
• 02:00
  Fractional flow reserve or intravascular ultrasound for guiding percutaneous coronary intervention of intermediate coronary stenoses? Sometimes apples and oranges have the same FLAVOUR Eur Heart J
  Comment on ‘Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI’, published in the New England Journal of Medicine (https://doi.org/10.1056/NEJMoa2201546).
• 02:00
  Unexpected find of native aortic leaflet thrombus during surgical myocardial revascularization Eur Heart J
  A 47-year-old woman was referred from a regional hospital for surgical myocardial revascularization after non-ST-elevation myocardial infarction. Medical history reported dyslipidaemia, hypothyroidism, endometriosis surgery, and a family history of thromboembolism. Coronary angiogram and (...)

25 October

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Iron deficiency and cardiovascular disease Eur Heart J
  AbstractIron deficiency (ID) is common in patients with cardiovascular disease. Up to 60% of patients with coronary artery disease, and an even higher proportion of those with heart failure (HF) or pulmonary hypertension have ID; the evidence for cerebrovascular disease, aortic stenosis and (...)
• 02:00
  Blood pressure lowering and prevention of dementia: an individual patient data meta-analysis Eur Heart J
  AbstractAimsObservational studies indicate U-shaped associations of blood pressure (BP) and incident dementia in older age, but randomized controlled trials of BP-lowering treatment show mixed results on this outcome in hypertensive patients. A pooled individual participant data analysis of (...)

21 October

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Genomic risk scores, biomolecules, and clinical conditions to predict atrial fibrillation: time to integrate what we can measure Eur Heart J

20 October

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Factor XI inhibitors: cardiovascular perspectives Eur Heart J
  AbstractAnticoagulants are the cornerstone for prevention and treatment of thrombosis but are not completely effective, and concerns about the risk of bleeding continue to limit their uptake. Animal studies and experience from patients with genetic coagulation factor XI deficiency suggesting (...)
• 02:00
  Troponin for risk stratification after CABG: just one piece of the puzzle Eur Heart J
  This commentary refers to ‘High-sensitivity cardiac troponin I after coronary artery bypass grafting for post-operative decision-making’, by H. Omran, https://doi.org/10.1093/eurheartj/ehab918 and the discussion piece ‘Cardiac troponin elevation after coronary artery bypass graft: improving risk (...)
• 02:00
  Cardiac troponin elevation after coronary artery bypass graft: improving risk stratification Eur Heart J
  This commentary refers to ‘High-sensitivity cardiac troponin I after coronary artery bypass grafting for post-operative decision-making’, by H. Omran, https://doi.org/10.1093/eurheartj/ehab918 and the discussion piece ‘Troponin for risk stratification after CABG: just one piece of the puzzle’, by (...)

19 October

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Pulmonary artery bone cement embolization resulting from percutaneous vertebroplasty Eur Heart J
  A 72-year-old woman presented with dyspnoea, chest tightness, and discomfort for 4 days. The patient had a history of percutaneous vertebroplasty (PVP) from a thoracic 12 vertebral compression fracture 2 years ago. The electrocardiogram was normal, and arterial blood gas analysis showed no (...)

18 October

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Too hot to handle? The truth about the effects of extreme heat on cardiovascular health Eur Heart J
  All correspondence relating to this article should be sent tocardiopulseⓐunicatt.it
• 02:00
  Emoji-like structure in the right atrium: identified as blood cyst and removed by interventional venous drainage cannula Eur Heart J
• 02:00
  Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial Eur Heart J
  AbstractAimsEffective and safe decongestion remains a major goal for optimal management of patients with acute heart failure (AHF). The effects of the sodium–glucose cotransporter 2 inhibitor empagliflozin on decongestion-related endpoints in the EMPULSE trial (NCT0415775) were evaluated.Methods (...)
• 02:00
  Long QT syndrome: long story short Eur Heart J
  the Swiss National Science Foundation10.13039/501100001711

6 October

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Heart Failure Association/European Society of Cardiology Atlas second edition: new insights into understanding the burden of heart failure Eur Heart J
  ESC10.13039/501100000860HFA10.13039/501100001028

29 September

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Future technologies in total artificial heart development: can a robot become as good as a donor heart? Eur Heart J
  European Union Horizon767195

28 September

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Valvular heart disease: shifting the focus to the myocardium Eur Heart J
  AbstractAdverse cardiac remodelling is the main determinant of patient prognosis in degenerative valvular heart disease (VHD). However, to give an indication for valvular intervention, current guidelines include parameters of cardiac chamber dilatation or function which are subject to (...)

17 September

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Management of post-infarction ventricular septal defects: are we moving forward? Eur Heart J
• 02:00
  Post-infarction ventricular septal defect: percutaneous or surgical management in the UK national registry Eur Heart J
  AbstractAimsPost-infarction ventricular septal defect (PIVSD) is a mechanical complication of acute myocardial infarction (AMI) with a poor prognosis. Surgical repair is the mainstay of treatment, although percutaneous closure is increasingly undertaken.Methods and resutsPatients treated with (...)

14 September

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Intravascular ultrasound and ultrasonic flow ratio-guided zero-contrast rotational atherectomy for calcified coronary lesions Eur Heart J
  A 63-year-old man with hypertension and hyperlipidaemia presented with effort angina 10 years ago. Immediately after administration of iodinated contrast, he developed haemodynamic collapse and cardiac arrest, which required brief cardiopulmonary resuscitation. A reattempt was undertaken 3 (...)

26 August

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme Eur Heart J
  AbstractAimsSodium-glucose co-transporter 2 (SGLT2) inhibitors improve cardiovascular outcomes in diverse patient populations, but their mechanism of action requires further study. The aim is to explore the effect of empagliflozin on the circulating levels of intracellular proteins in patients (...)

19 August

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Safety of non-vitamin K antagonist oral anticoagulants: concerns in patients with atrial fibrillation and glomerular hyperfiltration? Eur Heart J

18 August

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  A polygenic risk score predicts atrial fibrillation in cardiovascular disease Eur Heart J
  AbstractAimsInterest in targeted screening programmes for atrial fibrillation (AF) has increased, yet the role of genetics in identifying patients at highest risk of developing AF is unclear.Methods and resultsA total of 36,662 subjects without prior AF were analyzed from four TIMI trials. (...)

21 July

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  A focus on congenital heart disease and neonatal cardiac regeneration: an exciting future Eur Heart J

14 July

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Heart failure: how to optimize guideline-directed medical therapy Eur Heart J

7 July

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Cardiac magnetic resonance: challenges, opportunities, and developments Eur Heart J

1 July

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  The challenge of risk stratification in aortic aneurysms, congenital heart disease, and coronary bypass surgery Eur Heart J

27 June

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Heart failure medication: moving from evidence generation to implementation Eur Heart J

21 June

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Antiplatelet treatment of acute coronary syndromes: novel clinical and translational perspectives - Crea F. Eur Heart J

17 June

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Placing the risk of myopericarditis following COVID-19 vaccination into perspective Eur Heart J
  Comment on ‘Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis’ published in Lancet Respir Med.https://doi.org/10.1016/S2213-2600(22)00059-5.

14 June

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  The complex link among heart failure, atrial fibrillation, and lung diseases, and an update on cardiac transplantation - Crea F. Eur Heart J

8 June

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Right ventricular diverticulum: an uncommon cause of chest pain Eur Heart J
  A 50-year-old female without chronic disease presented with chest pain and echocardiography revealed a left ventricular aneurysm in the primary hospital. No positive results were observed in the physical examination, electrocardiogram (Panel A), myocardial necrotic marker, or coronary (...)
• 02:00
  Isolated posterior mitral leaflet elongation-related dynamic left ventricular outflow obstruction Eur Heart J
  A 31-year-old male presented with complaints of mild exertional dyspnoea (NYHA II) and atypical chest pain for 2 months. Cardiovascular examination revealed a systolic murmur, increasing in intensity on standing and decreasing with isometric handgrip. Electrocardiography showed poor precordial (...)
• 02:00
  A new score for life-threatening ventricular arrhythmias and sudden cardiac death in adults with transposition of the great arteries and a systemic right ventricle Eur Heart J
  AbstractAimsTo investigate the incidence of major adverse ventricular arrhythmias and related events (MAREs) and to develop a stratification tool predicting MAREs in adults with a systemic right ventricle (sRV).Methods and resultsIn a multicentre approach, all adults (?16 years old) with a sRV (...)
• 02:00
  Sudden cardiac death in adults with transposition of the great arteries and systemic right ventricles: preventing (night)MAREs Eur Heart J

6 June

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  New avenues in the prevention of sudden cardiac death - Crea F. Eur Heart J

2 June

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Long lasting effects of renal denervation: lights and shadows of the SPYRAL HTN-ON MED 3-year follow-up Eur Heart J
  Comment on the article ‘Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial’, published in The Lancet (https://doi.org/10.1016/S0140-6736(22)00455-X).

1 June

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  The challenge of cardiovascular prevention in the elderly: importance of randomized clinical trials - Crea F. Eur Heart J

26 May

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Early-stage amyloid transthyretin cardiomyopathy: uncertainties and opportunities Eur Heart J

25 May

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Obituary Joep Perk Eur Heart J
  On 10 April 2022, Preventive and Rehabilitative Cardiology lost one of its foremost representatives Professor Joep Perk (Figure 1), Oskarshamn, Sweden who unexpectedly died after a short period of illness at the age of 77.

24 May

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Three-dimensional printing, holograms, computational modelling, and artificial intelligence for adult congenital heart disease care: an exciting future Eur Heart J
  AbstractCongenital heart disease (CHD) is often comprised of complex three-dimensional (3D) anatomy that must be well understood to assess the pathophysiological consequences and guide therapy. Thus, detailed cardiac imaging for early detection and planning of interventional and/or surgical (...)
• 02:00
  Characteristics and natural history of early-stage cardiac transthyretin amyloidosis Eur Heart J
  AbstractAimsTransthyretin amyloid cardiomyopathy (ATTR-CM) is increasingly diagnosed at an early stage of the disease natural history, defined as National Amyloidosis Centre (NAC) ATTR Stage I. The natural history of early-stage ATTR-CM remains poorly characterized.Methods and resultsA (...)

22 May

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial Eur Heart J
  AbstractAimPatients with heart failure with reduced ejection fraction and low systolic blood pressure (SBP) have high mortality, hospitalizations, and poorly tolerate evidence-based medical treatment. Omecamtiv mecarbil may be particularly helpful in such patients. This study examined its (...)
• 02:00
  The promise of the metaverse in cardiovascular health Eur Heart J
  Since Mark Zuckerberg announced he was rebranding Facebook Inc as Meta Platforms in order to develop a metaverse, there has been much debate about the promise of such a technological concept. The use of virtual reality (VR) has been analysed in evidence-based studies in niche areas, but the (...)
• 02:00
  A laboratory viewpoint of the consensus paper from the European Society of Cardiology regarding the utilization of the American College of Medical Genetics and Genomics pathogenic criteria for cardiomyopathy Eur Heart J
  This commentary refers to ‘Interpretation and actionability of genetic variants in cardiomyopathies: a position statement from the European Society of Cardiology Council on cardiovascular genomics’, by E. Arbustini et al., https://doi.org/10.1093/eurheartj/ehab895and the discussion piece (...)
• 02:00
  Interpretation of genetic variants depends on a clinically guided integration of phenotype and molecular data Eur Heart J
  This commentary refers to ‘Interpretation and actionability of genetic variants in cardiomyopathies: a position statement from the European Society of Cardiology Council on cardiovascular genomics’, by E. Arbustini et al., https://doi.org/10.1093/eurheartj/ehab895 and the discussion piece ‘A (...)
• 02:00
  Doubly committed ventricular septal defect closure using an eccentric occluder via minimal incision in the anterior median sternum through the left parasternal third intercostal space Eur Heart J
  A girl was 11 months and 14 days old, weighing 8.5 kg, and was diagnosed with doubly committed ventricular septal defect (DCVSD) by transthoracic echocardiography. These defects may lead to aortic valve prolapse and regurgitation, so they should be closed (...)

20 May

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Challenges in heart failure: from actionability of genetic variants in cardiopmyopathies to new therapeutic targets - Crea F. Eur Heart J

17 May

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  The athlete’s heart from Philippides to the modern marathon runners Eur Heart J
  There are in fact two things, science and opinion. The former begets knowledge, the latter ignorance..Hippocrates, Paul Potter (1984). ‘Hippocrates’
• 02:00
  Sports cardiology in Europe from the ancient Greek-Roman era to the present Eur Heart J
  If we could give every individual the right amount of nourishment and exercise, not too little and not too much, we would have found the safest way to health.Hippocrates

16 May

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Puncture of the anterior wall of the pericardium by a fish bone from an oesophageal perforation Eur Heart J
  Oesophageal perforation is a life-threatening emergency. Only three cases have been reported in which the posterior wall pericardium was simultaneously punctured by foreign body from an oesophageal perforation. We report the first highly unlikely case with the anterior wall of the pericardium (...)
• 02:00
  Cardiovascular magnetic resonance for the assessment of left ventricular filling pressure in heart failure Eur Heart J

14 May

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  New therapeutic targets to reduce inflammation-associated cardiovascular risk: the CCL2–CCR2 axis, LOX-1, and IRF5 - Crea F. Eur Heart J

13 May

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  T cells: a ‘hidden corner’ to be explored for treating heart failure Eur Heart J
• 02:00
  Acute necrotizing eosinophilic myocarditis after COVID-19 vaccination Eur Heart J
  A 41-year-old male patient who had achieved HIV viral suppression presented with dyspnoea, accompanied by pulmonary oedema on chest X-ray. He developed a high fever and myalgia 10 days after a third-dose BNT162b2 vaccine against COVID-19. The patient had no previous history of severe acute (...)
• 02:00
  Treatment of mild hypertension improves pregnancy outcomes Eur Heart J
  Comment on ‘Treatment for Mild Chronic Hypertension during Pregnancy’ which was published in the New England Journal of Medicine, https://doi.org/10.1056/NEJMoa2201295.
• 02:00
  A novel inhibitor of Factor XIa as potential haemostasis-sparing anticoagulant for patients with atrial fibrillation Eur Heart J
  Comment on ‘Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study’ which was presented at the American College of Cardiology (ACC) 2022 (...)

11 May

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke Eur Heart J
  AbstractThe management of patients with stroke is often multidisciplinary, involving various specialties and healthcare professionals. Given the common shared risk factors for stroke and cardiovascular disease, input may also be required from the cardiovascular teams, as well as patient (...)

7 May

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  The risk of ‘hidden’ sodium and of low vitamin D levels - Crea F. Eur Heart J

6 May

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Autopsy in the era of advanced cardiovascular imaging Eur Heart J
  AbstractHistorically, autopsy contributed to our current knowledge of cardiovascular anatomy, physiology, and pathology. Major advances in the understanding of cardiovascular diseases, including atherosclerosis and coronary artery disease, congenital heart diseases, and cardiomyopathies, were (...)
• 02:00
  Detection of risk factors in childhood: a new perspective in cardiovascular prevention - Volpe M, Galiuto L. Eur Heart J
  Comment on “Childhood Cardiovascular Risk Factors and Adult Cardiovascular Events” which was published in the New England Journal of Medicine, https://doi.org/10.1056/NEJMoa2109191.

5 May

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  The European Heart Journal: fulfilling the mission - Crea F, Badimon L, Berry C, et al. Eur Heart J
  AbstractIn September 2020, the new Editors of the European Heart Journal (EHJ) wrote the following in their inaugural editorial: “The fundamental mission of the Journal remains the reduction of the global burden of cardiovascular disease. We aspire to advance this aim by worldwide teamwork to (...)

4 May

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies Eur Heart J
  AbstractMost patients survive acute myocardial infarction (MI). Yet this encouraging development has certain drawbacks: heart failure (HF) prevalence is increasing and patients affected tend to have more comorbidities worsening economic strain on healthcare systems and impeding effective (...)
• 02:00
  Cardiac magnetic resonance identifies raised left ventricular filling pressure: prognostic implications Eur Heart J
  AbstractAimsNon-invasive imaging is routinely used to estimate left ventricular (LV) filling pressure (LVFP) in heart failure (HF). Cardiovascular magnetic resonance (CMR) is emerging as an important imaging tool for sub-phenotyping HF. However, currently, LVFP cannot be estimated from CMR. (...)

3 May

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  CRT-P or CRT-D in heart failure patients: the RESET-CRT project—a prelude to the randomized controlled RESET-CRT study Eur Heart J
• 02:00
  A call to embrace a culture of openness in cardiovascular research - Cobey K, Liu P. Eur Heart J
  If we have learned anything as a biomedical research community in the past 2 years because of the COVID-19 pandemic, it is that there are major unaddressed challenges and inefficiencies in how research is traditionally conducted and disseminated. This ‘inefficiency’ in biomedical research has (...)

2 May

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  The COVID-19 pandemic and heart failure: lessons from GUIDE-HF Eur Heart J
• 02:00
  DISCO study suggests that less is more regarding antiplatelet therapy in spontaneous coronary artery dissection Eur Heart J
  This commentary refers to ‘Antiplatelet therapy in patients with conservatively managed spontaneous coronary artery dissection from the multicentre DISCO registry’, by E. Cerrato et al., https://doi.org/10.1093/eurheartj/ehab372 and the discussion piece ‘Dual antiplatelet therapy analysis (...)
• 02:00
  Dual antiplatelet therapy analysis inconclusive in DISCO registry for spontaneous coronary artery dissection Eur Heart J
  This commentary refers to ‘Antiplatelet therapy in patients with conservatively managed spontaneous coronary artery dissection from the multicentre DISCO registry’, by E. Cerrato et al., https://doi.org/10.1093/eurheartj/ehab372 and the discussion piece ‘DISCO study suggests that less is more (...)

1 May

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Valvular heart disease: the quest for new pharmacological targets - Crea F. Eur Heart J

30 April

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Complete primary aortic ascending thrombosis resolution after dabigatran therapy Eur Heart J
  A 36-year-old man visited hospital with chest pain and shortness of breath since a few days. There was no medical history. Due to troponin elevation 0.07 µg/L (normal Panels A and B). No clue for dissection or other wall pathologies were found, normal size of the ascending aorta, no sign of (...)

28 April

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Corrigendum to: Targeting the CCL2–CCR2 axis for atheroprotection Eur Heart J
  European Heart Journal, https://doi.org/10.1093/eurheartj/ehac094.

26 April

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Corrigendum to: Backup natural pacemaker found in the heart Eur Heart J
  European Heart Journal, https://doi.org/10.1093/eurheartj/ehab199.

25 April

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Accelerated and personalized therapy for heart failure with reduced ejection fraction Eur Heart J
  AbstractAimsPreviously, guidelines recommended initiating therapy in patients with heart failure and reduced ejection fraction (HFrEF) in a sequence that follows the chronological order in which trials were conducted, with cautious up-titration of each treatment. It remains unclear whether this (...)
• 02:00
  The PACMAN-AMI trial: game over for the “vulnerable plaque”? - Vergallo R, Patrono C. Eur Heart J
  Comment on the article ‘Effect of alirocumab added to high-intensity statin therapy on coronary atherosclerosis in patients with acute myocardial infarction: the PACMAN-AMI randomized clinical trial’, published in JAMA, doi:10.1001/jama.2022.5218.
• 02:00
  Lung function impairment and risk of incident heart failure: the NHLBI Pooled Cohorts Study - Eckhardt C, Balte P, Barr R, et al. Eur Heart J
  AbstractAimsThe aim is to evaluate associations of lung function impairment with risk of incident heart failure (HF).Methods and resultsData were pooled across eight US population-based cohorts that enrolled participants from 1987 to 2004. Participants with self-reported baseline cardiovascular (...)
• 02:00
  HFp2EF: heart failure with pulmonary dysfunction and preserved ejection fraction? - Maron B, Humbert M. Eur Heart J

22 April

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Left main revascularization: an evidence-based reconciliation Eur Heart J
• 02:00
  Stereotactic radioablation to treat ventricular tachycardia related to a left ventricular mass - Ninni S, Longere B, Mirabel X. Eur Heart J
• 02:00
  Infectious endarteritis associated with patent ductus arteriosus and vegetation: a challenging diagnosis and treatment - Ku L, Cheng Y, Ma X. Eur Heart J
• 02:00
  The end of aspirin for dementia prevention in diabetes? - Kristensen S, Olesen K, Maeng M. Eur Heart J

20 April

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Meeting challenges with meetings tailored to challenging times: the ESC Acute CardioVascular Care Congress, March 2022 Eur Heart J
  The 2022 congress of the ESC Association for Acute CardioVascular Care (ACVC) took place virtually this year. Although the format of #ACVC2022 changed due to the ongoing uncertainty of the COVID-19 pandemic, the focus of both the congress and ACVC remains on the acutely and critically ill (...)
• 02:00
  How delivering cardiopulmonary resuscitation and basic life support skills training through places of worship can help save lives and address health inequalities - Khanji M, Waqar S, Khawaja Z, et al. Eur Heart J
• 02:00
  Data standards for heart failure: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart) - Aktaa S, Batra G, Cleland J, et al. Eur Heart J
  AbstractStandardized data definitions are essential for assessing the quality of care and patient outcomes in observational studies and randomized controlled trials. The European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart) project of the European Society of (...)
• 02:00
  Heart transplantation: focus on donor recovery strategies, left ventricular assist devices, and novel therapies - Crespo-Leiro M, Costanzo M, Gustafsson F, et al. Eur Heart J
  AbstractHeart transplantation is advocated in selected patients with advanced heart failure in the absence of contraindications. Principal challenges in heart transplantation centre around an insufficient and underutilized donor organ pool, the need to individualize titration of (...)
• 02:00
  A deleterious interaction between omecamtiv mecarbil and atrial fibrillation in patients with heart failure: an influence of digoxin? - van der Meer P, Rienstra M, van Veldhuisen D. Eur Heart J
• 02:00
  Heart failure with normal natriuretic peptide levels: more fat, and that is the main problem - Verbrugge F, Borlaug B. Eur Heart J
  This commentary refers to ‘Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality’, by F.H. Verbrugge et al., https://doi.org/10.1093/eurheartj/ehab911 and the discussion piece ‘Mixing the fat with (...)
• 02:00
  Mixing the fat with water: are normal natriuretic peptide heart failure with preserved ejection fraction patients just more obese? - Olivella A, Méndez A, Ferreira-González I. Eur Heart J
  This commentary refers to ‘Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality’, by F.H. Verbrugge et al., https://doi.org/10.1093/eurheartj/ehab911 and the discussion piece ‘Heart failure with (...)

19 April

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  In vivo generated chimeric antigen receptor T cells reduce fibrosis and restore cardiac function in experimental heart failure - Liuzzo G, Patrono C. Eur Heart J
  Comment on ‘CAR T cells produced in vivo to treat cardiac injury’ published in Science (https://doi.org/10.1126/science.abm0594).

18 April

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Corrigendum to: A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy Eur Heart J
  A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy

14 April

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Adult T-cells impair neonatal cardiac regeneration Eur Heart J
  AbstractAimsNewborn mice and humans display transient cardiac regenerative potential that rapidly declines postnatally. Patients who survive a myocardial infarction (MI) often develop chronic heart failure due to the heart’s poor regeneration capacity. We hypothesized that the cardiac (...)
• 02:00
  Fighting against sudden cardiac death: the new frontiers - Crea F. Eur Heart J

13 April

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  The importance of time-to-event analysis in measuring the prognostic impact of coronary flow reserve - Kelshiker M, Seligman H, Howard J, et al. Eur Heart J
  This commentary refers to ‘Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis’, by M.A. Kelshiker et al., https://doi.org/10.1093/eurheartj/ehab775 and the discussion piece ‘An attempt to better show some results such as the comparison of mortality and major (...)
• 02:00
  An attempt to better show some results such as the comparison of mortality and major adverse cardiovascular events between the abnormal and normal coronary flow reserve cohorts - Zhu H, Chen T, Huang J. Eur Heart J
  This commentary refers to ‘Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis’, by M.A. Kelshiker et al., https://doi.org/10.1093/eurheartj/ehab775 and the discussion piece ‘The importance of time-to-event analysis in measuring the prognostic impact of (...)
• 02:00
  Hospitalization for heart failure: a window of opportunity - Wachter R, Rommel K. Eur Heart J
• 02:00
  Increased risk of incident diabetes in patients with long COVID - Paneni F, Patrono C. Eur Heart J
  Comment on ‘Risks and burdens of incident diabetes in long COVID: a cohort study’ which was published in Lancet Diabetes Endocrinol (https://doi.org/10.1016/S2213-8587(22)00044-4).
• 02:00
  Pointing a FINGER at the contribution of lifestyle to cardiovascular events and dementia - Noutsias M, Hauptmann M, Völler H. Eur Heart J
• 02:00
  The DISCHARGE trial: imaging a new strategy for the clinical management of stable chest pain? - Vergallo R, Volpe M. Eur Heart J
  Comment on the article ‘CT or invasive coronary angiography in stable chest pain’, published in the New England Journal of Medicine (https://doi.org/10.1056/NEJMoa2200963).

11 April

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Age at first syncope: a consideration for assessing probable cause? - Colburn S, Benditt DG. Eur Heart J

8 April

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Master switches in cardiac ischaemia: the Collaborative Research Center (CRC) 1116 of the German Research Foundation Eur Heart J
  German Research Foundation10.13039/501100001659
• 02:00
  Corrigendum to: P2Y12 inhibitor adherence trajectories in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prognostic implications Eur Heart J
  European Heart Journal, https://doi.org/10.1093/eurheartj/ehac116.
• 02:00
  Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction - Tromp J, Ouwerkerk W, Teng T, et al. Eur Heart J
  AbstractBackgroundHeart failure (HF) is a global challenge, with lower- and middle-income countries (LMICs) carrying a large share of the burden. Treatment for HF with reduced ejection fraction (HFrEF) improves survival but is often underused. Economic factors might have an important effect on (...)
• 02:00
  Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial - Parish S, Mafham M, Offer A, et al. Eur Heart J
  AbstractAimsAspirin is widely used in cardiovascular disease prevention but is also associated with an increased risk of bleeding. The net effect of aspirin on dementia and cognitive impairment is uncertain.Methods and resultsIn the ASCEND trial, 15 480 people from the UK with diabetes and no (...)

7 April

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Transcatheter closure of a rare ruptured giant non-coronary Valsalva sinus aneurysm - Shen Q, Deng X, Jing C, et al. Eur Heart J
  A 40-year-old male patient was admitted to hospital due to paroxysmal palpitations in the recent 2 months. Heart auscultation found continuous murmurs and electrocardiogram monitoring showed frequent short ventricular tachycardia. Computed tomography angiography revealed that a giant aneurysm (...)
• 02:00
  Double aortic arch with aortic arch diverticulum leading to the use of tracheal intubation in a newborn - Zhu J, Zou J, Zhu S, et al. Eur Heart J
• 02:00
  Soluble LOX-1 levels during acute coronary syndrome: a potent and multifaceted warning sign for cardiovascular risk - Sposito A. Eur Heart J
• 02:00
  Twitter promotion is associated with higher citation rates of cardiovascular articles: the ESC Journals Randomized Study - Ladeiras-Lopes R, Vidal-Perez R, Santos-Ferreira D, et al. Eur Heart J
  AbstractThe association between the dissemination of scientific articles on Twitter and online visibility (as assessed by the Altmetric Score) is still controversial, and the impact on citation rates has never been rigorously addressed for cardiovascular medicine journals using a randomized (...)

6 April

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Cardiac cell therapy: a call for action Eur Heart J
• 02:00
  Attentive follow-up to counter alarmism - Twerenbold R, Cavus E, Blankenberg S. Eur Heart J
  This commentary refers to ‘Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme’ by E.L. Petersen et al., https://doi.org/10.1093/eurheartj/ehab914 and the discussion piece ‘Alarmist reporting on the pandemic: time (...)
• 02:00
  Alarmist reporting on the pandemic: time to say no! - Roy A. Eur Heart J
  This commentary refers to ‘Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme’ by E.L. Petersen et al., https://doi.org/10.1093/eurheartj/ehab914 and the discussion piece ‘Attentive follow-up to counter alarmism’ (...)
• 02:00
  Is there an increased incidence of subclinical proximal deep vein thrombosis after mild to moderate course of SARS-CoV-2 infection? - Müller L, Mendoza E, Stücker M. Eur Heart J
  This commentary refers to ‘Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme’ by E.L. Petersen et al., https://doi.org/10.1093/eurheartj/ehab914 and the discussion piece ‘The everlasting challenge to identify (...)
• 02:00
  The everlasting challenge to identify deep vein thrombosis in both clinical practice and research - Behrendt C, Twerenbold R, Blankenberg S. Eur Heart J
  This commentary refers to ‘Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme’ by E.L. Petersen et al., https://doi.org/10.1093/eurheartj/ehab914 and the discussion piece ‘Is there an increased incidence of (...)

5 April

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Data standards for acute coronary syndrome and percutaneous coronary intervention: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart) - , , , et al. Eur Heart J
  AbstractStandardized data definitions are essential for monitoring and benchmarking the quality of care and patient outcomes in observational studies and randomized controlled trials. There are no contemporary pan-European data standards for the acute coronary syndrome (ACS) and percutaneous (...)

1 April

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Long-term results of first-generation S-ICD systems: strong from the start and through the threats of time - Cappato R. Eur Heart J
• 02:00
  SARS-CoV-2 infection markedly increases long-term cardiovascular risk - Liuzzo G, Volpe M. Eur Heart J
  Comment on ‘Long-term cardiovascular outcomes of COVID-19’ which was published in Nat Med. https://doi.org/10.1038/s41591-022-01689-3.

30 March

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Prevention is better than cure but is not always possible in challenging circumstances Eur Heart J
  All correspondence relating to this article should be sent tocardiopulseⓐunicatt.it
• 02:00
  Left main bifurcation treatment: is one stent enough? - den Dekker W, Mahmoud K, Boersma E. Eur Heart J
  This commentary refers to ‘The European bifurcation club Left Main Coronary Stent study: a randomized comparison of stepwise provisional vs. systematic dual stenting strategies (EBC MAIN)’, by D. Hildick-Smith et al., https://doi.org/10.1093/eurheartj/ehab283 and the discussion piece ‘The (...)
• 02:00
  The stepwise provisional approach to left main stem bifurcations in Europe - Hildick-Smith D. Eur Heart J
  This commentary refers to ‘The European bifurcation club Left Main Coronary Stent study: a randomized comparison of stepwise provisional vs. systematic dual stenting strategies (EBC MAIN)’, by D. Hildick-Smith et al., https://doi.org/10.1093/eurheartj/ehab283 and the discussion piece ‘Left main (...)
• 02:00
  Increased cardiovascular risk in boys born with hypospadias: intriguing observations and remaining questions - Kränkel N. Eur Heart J

24 March

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  A novel exosome-based therapy for post-MI arrhythmias - Cacheux M, Akar F. Eur Heart J
• 01:00
  Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromes - Kraler S, Wenzl F, Georgiopoulos G, et al. Eur Heart J
  AbstractAimsThe lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) and its shedding product [soluble LOX-1 (sLOX-1)] are implicated in atherosclerotic cardiovascular disease (ASCVD) pathogenesis. Herein, we examined the relationship of sLOX-1 with both fatal events and plaque (...)
• 01:00
  Mischief in the marrow: a root of cardiovascular evil - Libby P, Nahrendorf M, Swirski F. Eur Heart J

23 March

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial - Solomon S, Claggett B, Miao Z, et al. Eur Heart J
  AbstractAimsIn GALACTIC-HF, the cardiac myosin activator omecamtiv mecarbil compared with placebo reduced the risk of heart failure events or cardiovascular death in patients with heart failure with reduced ejection fraction. We explored the influence of atrial fibrillation or flutter (AFF) on (...)

22 March

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  In memoriam—Dr. Hikaru Sato: the discoverer of Takotsubo syndrome - Nagai M, Dote K, Ishihara M, et al. Eur Heart J
  A pioneer of Japanese reperfusion therapy for acute myocardial infarction, the discoverer and outstanding researcher of ‘Takotsubo syndrome’ passed away on 10 November 2021

19 March

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Early stakeholder engagement lessons from managing hypertension among people living with human-immunodeficiency virus: an integrated model (MAP-IT) Eur Heart J
  National Heart Lung and Blood Institute, United States of America1UG3HL152381-01

18 March

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Survival of patients undergoing cardiac resynchronization therapy with or without defibrillator: the RESET-CRT project Eur Heart J
  AbstractAimsCardiac resynchronization therapy (CRT) is an established treatment for heart failure. There is contradictory evidence whether defibrillator capability improves prognosis in patients receiving CRT. We compared the survival of patients undergoing de novo implantation of a CRT with (...)
• 01:00
  Sudden cardiac death in congenital heart disease - Khairy P, Silka M, Moore J, et al. Eur Heart J
  AbstractSudden cardiac death (SCD) accounts for up to 25% of deaths in patients with congenital heart disease (CHD). To date, research has largely been driven by observational studies and real-world experience. Drawbacks include varying definitions, incomplete taxonomy that considers SCD as a (...)
• 01:00
  Cardiac sympathetic denervation in the prevention of genetically mediated life-threatening ventricular arrhythmias - Schwartz PJ, Ackerman MJ. Eur Heart J
  AbstractProper management of patients affected by genetic disorders causing life-threatening arrhythmias is important for several reasons, including even societal ones, given the predominantly young age of those affected. Incorrect management often has dire consequences, ranging from (...)
• 01:00
  BNP: Biomarker Not Perfect in heart failure with preserved ejection fraction - Shah S. Eur Heart J

17 March

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Massive device thrombosis, multiple embolisms, and delayed-onset heparin-induced thrombocytopenia: a rare but severe complication of patent foramen ovale closure Eur Heart J
  A 40-year-old man was referred to our centre for a patent foramen ovale (PFO) closure 8 months after a cryptogenic stroke. A Cardioform Septal Occluder device (GSO; W.L. Gore and Associates) was successfully positioned with transoesophageal echocardiography (TEE) guidance. A 100 UI/kg bolus of (...)
• 01:00
  Revisiting the definition of perioperative myocardial infarction after coronary artery bypass grafting Eur Heart J
• 01:00
  P2Y12 inhibitor adherence trajectories in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prognostic implications - Turgeon R, Koshman S, Dong Y, et al. Eur Heart J
  AbstractAimsPost-acute coronary syndrome (ACS) P2Y12 inhibitor non-adherence is common and associated with greater risk of major adverse cardiovascular events (MACEs). Non-adherence can follow different trajectories from an inability to initiate, implement, or continue therapy for the intended (...)
• 01:00
  Adherence to P2Y12 inhibitors in acute coronary syndrome after a percutaneous coronary intervention: what can we improve? - Han Y, Li Y. Eur Heart J
• 01:00
  Encouraging physical activity amongst older adults; where should we stand? - Hellénius M. Eur Heart J
• 01:00
  Vascular dysfunction and increased cardiovascular risk in hypospadias - Lucas-Herald A, Montezano A, Alves-Lopes R, et al. Eur Heart J
  AbstractAimsHypogonadism is associated with cardiovascular disease. However, the cardiovascular impact of hypogonadism during development is unknown. Using hypospadias as a surrogate of hypogonadism, we investigated whether hypospadias is associated with vascular dysfunction and is a risk (...)

16 March

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Cereblon, a novel target in heart failure: but is calcium really everything? - Sequeira V, Maack C. Eur Heart J
• 01:00
  800 years of research at the University of Padua (1222–2022): contemporary insights into Sports Cardiology - Corrado D, Zorzi A, Basso C, et al. Eur Heart J
  Holding a long tradition of excellence since 1222, the University of Padua is one of the oldest and most prestigious academic centres in Europe. In the 16th–17th centuries, milestone achievements from Padua's researchers in astronomy, medicine, and natural philosophy contributed to the cultural (...)

11 March

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Corrigendum to: Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists Eur Heart J
  European Heart Journal, https://doi.org/10.1093/eurheartj/ehaa1044.
• 01:00
  Bone marrow activation in response to metabolic syndrome and early atherosclerosis - Devesa A, Lobo-González M, Martínez-Milla J, et al. Eur Heart J
  AbstractAimsExperimental studies suggest that increased bone marrow (BM) activity is involved in the association between cardiovascular risk factors and inflammation in atherosclerosis. However, human data to support this association are sparse. The purpose was to study the association between (...)
• 01:00
  Corrigendum to: Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology Eur Heart J
  European Heart Journal, https://doi.org/10.1093/eurheartj/ehab834.

10 March

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  The GUIDE-HF trial of pulmonary artery pressure monitoring in heart failure: impact of the COVID-19 pandemic Eur Heart J
  AbstractAimsDuring the coronavirus disease 2019 (COVID-19) pandemic, important changes in heart failure (HF) event rates have been widely reported, but few data address potential causes for these changes; several possibilities were examined in the GUIDE-HF study.Methods and resultsFrom 15 March (...)
• 01:00
  Circadian nuclear receptor Rev-erb? is expressed by platelets and potentiates platelet activation and thrombus formation - Shi J, Tong R, Zhou M, et al. Eur Heart J
  AbstractAimsAdverse cardiovascular events have day/night patterns with peaks in the morning, potentially related to endogenous circadian clock control of platelet activation. Circadian nuclear receptor Rev-erb? is an essential and negative component of the circadian clock. To date, the (...)
• 01:00
  Chrono-pharmacology-based antiplatelet therapy for acute myocardial infarction - Tual-Chalot S, Stellos K. Eur Heart J
• 01:00
  Electrical management of heart failure: from pathophysiology to treatment - Prinzen F, Auricchio A, Mullens W, et al. Eur Heart J
  AbstractElectrical disturbances, such as atrial fibrillation (AF), dyssynchrony, tachycardia, and premature ventricular contractions (PVCs), are present in most patients with heart failure (HF). While these disturbances may be the consequence of HF, increasing evidence suggests that they may (...)
• 01:00
  Metabolic/bariatric surgery protects against cardiovascular disease - Mingrone G, Castagneto-Gissey L, Bornstein S. Eur Heart J
• 01:00
  Coronary artery fistula bypassed the left main coronary artery blocked by a large cardiogenic thrombus - Wang J, Chen H, Zhang L. Eur Heart J
  Wuhan Asia General Hospital
• 01:00
  To repair or not to repair: the dilemma of tricuspid regurgitation associated with left-sided valvular heart disease - Galiuto L, Massetti M. Eur Heart J
  Comment on ‘Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation’ published in the New England Journal of Medicine (https://doi.org/10.1056/NEJMoa2115961).
• 01:00
  Risk scoring in secondary prevention: a basis for informed clinical decisions in the context of ever-expanding treatments - Sattar N, Welsh P. Eur Heart J
• 01:00
  Mitral valve prolapse: will genetics finally solve the puzzle? - Trenkwalder T, Krane M. Eur Heart J

9 March

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Biological substrate modification suppresses ventricular arrhythmias in a porcine model of chronic ischaemic cardiomyopathy - Dawkins JF, Ehdaie A, Rogers R, et al. Eur Heart J
  AbstractAimsCardiomyopathy patients are prone to ventricular arrhythmias (VA) and sudden cardiac death. Current therapies to prevent VA include radiofrequency ablation to destroy slowly conducting pathways of viable myocardium which support re-entry. Here, we tested the reverse concept, namely (...)

8 March

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Climate change and healthcare organizations: a call to arms Eur Heart J
  The 26th UN Climate Change Conference of the Parties (COP26), which concluded on 13 November 2021, was the latest in more than two decades of a United Nations-facilitated effort to help stave off climate change. The outcome known as the Glasgow Climate Pact, called on 197 countries to report (...)
• 01:00
  Advanced subspecialty cardiology training in India in 2022: challenges and future directions - Bhat V, Ozair A, Kumar A, et al. Eur Heart J
• 01:00
  European Reference Network for rare, low prevalence, or complex diseases of the heart (ERN GUARD-Heart): 5 year anniversary - Amin A, Biller R, Charron P, et al. Eur Heart J
• 01:00
  Cardiotoxicity from chimeric antigen receptor-T cell therapy for advanced malignancies - Totzeck M, Michel L, Lin Y, et al. Eur Heart J
  AbstractChimeric antigen receptor (CAR)-T cell therapy is the next revolutionary advance in cancer therapy. By using ex vivo engineered T cells to specifically target antigens, a targeted immune reaction is induced. Chimeric antigen receptor-T cell therapy is approved for patients suffering (...)
• 01:00
  Unloading left heart with a shunt device shows no benefits in heart failure with preserved ejection fraction but supports the importance of phenotyping patients in clinical trials - Volpe M, Liuzzo G. Eur Heart J
  Comment on ‘Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomized, multicentre, blinded, sham-controlled trial’ which was published in The Lancet, https://doi.org/10.1016/S0140-6736(22)00016-2.

7 March

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Targeting the CCL2–CCR2 axis for atheroprotection - Georgakis M, Bernhagen J, Heitman L, et al. Eur Heart J
  AbstractDecades of research have established atherosclerosis as an inflammatory disease. Only recently though, clinical trials provided proof-of-concept evidence for the efficacy of anti-inflammatory strategies with respect to cardiovascular events, thus offering a new paradigm for lowering (...)
• 01:00
  Complete resolution of apical hypertrophy and fibrosis: the role of serial cardiovascular magnetic resonance tissue characterization to differentiate hypertrophic cardiomyopathy from myocarditis - Wilson J, Muthumala A, Khanji M. Eur Heart J
  A 71-year-old female with Type 2 diabetes mellitus, hypertension, and hypercholesterolaemia presented to the emergency department with a 2-day history of heavy chest pain radiating to the left shoulder. Electrocardiogram showed normal sinus rhythm with no evidence of ischaemia, but serial (...)
• 01:00
  Corrigendum to: Proteomics for the prediction and prevention of atherosclerotic disease Eur Heart J
  European Heart Journal, https://doi.org/10.1093/eurheartj/ehac036.

5 March

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Personalized antithrombotic treatment of cardiovascular disease: a glimpse into the future based on current knowledge - Crea F. Eur Heart J
• 01:00
  Time for a paradigm shift? Making the case for tailored selection of antiplatelet therapy - O’Donoghue ML, Marston NA. Eur Heart J
  This editorial refers to ‘Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials’, by M. Galli et al., https://doi.org/10.1093/eurheartj/ehab836.

4 March

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  A training project to promote clinical research among young cardiologists - Di Fusco S, Maggioni A, Colivicchi F. Eur Heart J
  Providing guidance to young cardiologists by promoting collaboration and professional development is one of the main goals that the Italian Association of Hospital Cardiologists (ANMCO) shares with the European Society of Cardiology. In 2021, the ANMCO President, Prof Furio Colivicchi, launched (...)
• 01:00
  Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis - van Veldhuisen S, Gorter T, van Woerden G, et al. Eur Heart J
  AbstractAimsObesity is a global health problem, associated with significant morbidity and mortality, often due to cardiovascular (CV) diseases. While bariatric surgery is increasingly performed in patients with obesity and reduces CV risk factors, its effect on CV disease is not established. We (...)
• 01:00
  Genome-wide association study reveals novel genetic loci: a new polygenic risk score for mitral valve prolapse - Roselli C, Yu M, Nauffal V, et al. Eur Heart J
  AbstractAimsMitral valve prolapse (MVP) is a common valvular heart disease with a prevalence of >2% in the general adult population. Despite this high incidence, there is a limited understanding of the molecular mechanism of this disease, and no medical therapy is available for this disease. We (...)

3 March

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Corrigendum to: European Heart Journal quality standards Eur Heart J
  European Heart Journal, https://doi:10.1093/eurheartj/ehab324.

2 March

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  NSTEMI management: a fall from GRACE? - Schiele F, Meneveau N. Eur Heart J

1 March

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Differential cardiovascular effects of disease-modifying antirheumatic drugs in rheumatoid arthritis - Galiuto L, Patrono C. Eur Heart J
  Comment on ‘Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis’ published in N Engl J Med. https://doi.org/10.1056/NEJMoa2109927.

25 February

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Advancing population-scale access to high-value cardiovascular care: a roadmap for CMR and beyond Eur Heart J
• 01:00
  Polygenic risk score: a tool ready for clinical use? - Kavousi M, Schunkert H. Eur Heart J
• 01:00
  Sodium-containing acetaminophen and cardiovascular outcomes in individuals with and without hypertension - Zeng C, Rosenberg L, Li X, et al. Eur Heart J
  AbstractAimsPrevious studies have found high sodium intake to be associated with increased risks of cardiovascular disease (CVD) and all-cause mortality among individuals with hypertension; findings on the effect of intake among individuals without hypertension have been equivocal. We aimed to (...)
• 01:00
  The sodium hidden in medication: a tough pill to swallow - Schutte A, Neal B. Eur Heart J

23 February

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study - Lu X, Liu Z, Cui Q, et al. Eur Heart J
  AbstractAimsTo construct a polygenic risk score (PRS) for coronary artery disease (CAD) and comprehensively evaluate its potential in clinical utility for primary prevention in Chinese populations.Methods and resultsUsing meta-analytic approach and large genome-wide association results for CAD (...)

22 February

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Corrigendum to: Nudging within learning health systems: next generation decision support to improve cardiovascular care Eur Heart J
  European Heart Journal,https://doi.org/10.1093/eurheartj/ehac030.
• 01:00
  Cereblon contributes to cardiac dysfunction by degrading Cav1.2? - Park N, Marquez J, Pham T, et al. Eur Heart J
  AbstractAimsCereblon (CRBN) is a substrate receptor of the E3 ubiquitin ligase complex that was reported to target ion channel proteins. L-type voltage-dependent Ca2+ channel (LTCC) density and dysfunction is a critical player in heart failure with reduced ejection fraction (HFrEF). However, (...)

21 February

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Is APAF-CRT robust enough to change clinical practice? - Brignole M, Soranna D, Rienstra M. Eur Heart J
  This commentary refers to ‘AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial’, by M. Brignole et al., https://doi.org/10.1093/eurheartj/ehab569 and the discussion piece ‘Ablate and pace for patients with (...)
• 01:00
  Ablate and pace for patients with atrial fibrillation: a fragile option? - Kaur H, McIntyre W, Belley-Côté E. Eur Heart J
  This commentary refers to ‘AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial’, by M. Brignole et al., https://doi.org/10.1093/eurheartj/ehab569 and the discussion piece ‘Is APAF-CRT robust enough to (...)
• 01:00
  Clinical strokes in atrial fibrillation: the tip of the iceberg - Jared Bunch T, Steinberg B. Eur Heart J
• 01:00
  Corrigendum to: 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J
  European Heart Journal, https://doi.org/10.1093/eurheartj/ehab395.
• 01:00
  Calcific aortic valve disease: novel insights into nitric oxide signalling - Kraler S, Garg V, Akhmedov A. Eur Heart J
• 01:00
  Inflammation, targeted proteomics, and microvascular dysfunction: the new frontiers of ischaemic heart disease - Crea F. Eur Heart J
• 01:00
  Percutaneous coronary intervention vs. coronary artery bypass graft for left main coronary artery disease: a never-ending debate - Liuzzo G, Volpe M. Eur Heart J
  Comment on ‘Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis’ published in Lancet. (https://doi.org/10.1016/S0140-6736(21)02334-5).

18 February

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  The Pan African Society of Cardiology and its commitment to clinical research training Eur Heart J
  African cardiologists first conceived the idea of forming a Pan African Society of Cardiology (PASCAR) in the 1970s, as the focus of the World Congress of Cardiology was solely on Europe and North America. In 1979, the president of the Nigerian Cardiac Society, Prof. Ayodele Falase, created the (...)
• 01:00
  Not only lungs: COVID-19 hits platelets as well - Bongiovanni D, Klug M, Valgimigli M, et al. Eur Heart J
  Despite the worldwide diffusion of SARS-CoV-2 infection, still little is known concerning the mechanism leading to multi-organ damage in coronavirus disease 2019 (COVID-19). It is now clear that the coronavirus does not only affect the pulmonary system but causes damage to several other (...)
• 01:00
  Serial histopathologic assessment of fulminant myocarditis after the first mRNA COVID-19 vaccine dose - Koiwaya H, Nishihira K, Tomozoe K, et al. Eur Heart J
  A 77-year-old man with hypertension presented to the emergency department with fever and cardiogenic shock 8 days after receiving the first dose of the BNT16B2b2 mRNA COVID-19 vaccine (Pfizer-BioNTech). Nucleic acid amplification via polymerase chain reaction with a nasopharyngeal swab sample (...)
• 01:00
  Percutaneous closure of left ventricular pseudoaneurysm after direct surgical mitral valve implantation of balloon-expandable transcatheter prosthesis in severe mitral annular calcification - Oechslin L, Corti R, Biaggi P, et al. Eur Heart J
  A 76-year-old female patient who had undergone quadruple coronary bypass surgery and aortic valve replacement 10 years earlier was referred to our clinic for severe symptomatic mitral valve stenosis secondary to extensive mitral annular calcification (MAC). Due to the high surgical risk, the (...)
• 01:00
  Heart and kidney: towards an integrated approach to secondary mitral regurgitation - Rudolph V. Eur Heart J

17 February

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Ethnicity-dependent performance of the Global Registry of Acute Coronary Events risk score for prediction of non-ST-segment elevation myocardial infarction in-hospital mortality: nationwide cohort study - Moledina S, Kontopantelis E, Wijeysundera H, et al. Eur Heart J
  AbstractAimsThe Global Registry of Acute Coronary Events (GRACE) score was developed to evaluate risk in patients with the acute coronary syndrome with or without ST-segment elevation. Little is known about its performance at predicting in-hospital mortality for ethnic minority patients.Methods (...)
• 01:00
  Renal denervation therapy for hypertension: all that glitters is not gold - Ram C. Eur Heart J
  Systemic hypertension is a common condition that substantially increases the risk of cardiovascular events. Despite this, blood pressure (BP) control with pharmacological antihypertensive therapy remains challenging and control rates are well below the optimal level. This common unmet need (...)
• 01:00
  Silent brain infarcts impact on cognitive function in atrial fibrillation - Kühne M, Krisai P, Coslovsky M, et al. Eur Heart J
  AbstractAimsWe aimed to investigate the association of clinically overt and silent brain lesions with cognitive function in atrial fibrillation (AF) patients.Methods and resultsWe enrolled 1227 AF patients in a prospective, multicentre cohort study (Swiss-AF). Patients underwent standardized (...)
• 01:00
  Corrigendum to: 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy Eur Heart J
  European Heart Journal, https://doi.org/10.1093/eurheartj/ehab364.
• 01:00
  Corrigendum to: PCSK9 inhibition in patients with heart failure – neutral or harmful intervention? Eur Heart J
  European Heart Journal, https://doi.org/10.1093/eurheartj/ehab913.

16 February

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Strengthening the ties between Europe and Arabia Eur Heart J
  As part of the European Society of Cardiology's (ESC) Global Activities, the ESC in Arabia programme saw international experts deliver a series of educational courses to the 32nd Annual Conference of the Saudi Heart Association (SHA) 2021. Held virtually, and in collaboration with the SHA on (...)

15 February

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  High-sensitivity cardiac troponin I after coronary artery bypass grafting for post-operative decision-making Eur Heart J
  AbstractAimsCurrent troponin cut-offs suggested for the post-operative workup of patients following coronary artery bypass graft (CABG) surgery are based on studies using non-high-sensitive troponin assays or are arbitrarily chosen. We aimed to identify an optimal cut-off and timing for a (...)
• 01:00
  Hybrid aortic arch repair for unibody single-branched endograft induced retrograde aortic dissection - Zhang Y, Yang P, Lu C, et al. Eur Heart J
  National Natural Science Foundation of China10.13039/50110000180981670327Sichuan Science and Technology Program2019YJ00462018SZ0384West China Hospital, Sichuan University10.13039/5011000133652020HXJS0152019HXFH027
• 01:00
  Unmet needs in the management of arrhythmias among heart failure patients in Africa - Mutagaywa R, Chin A, Karaye K, et al. Eur Heart J
  Several studies suggest that the burden of heart failure (HF) in Africa is on the increase with patients presenting late to hospitals.1 Such a high burden is fuelled by an increase in the prevalence of cardiovascular risk factors, sub-optimal management of these risk factors, and an ageing (...)
• 01:00
  A polypill for cardiovascular disease prevention with a focus on non-alcohol steatohepatitis - Joseph P, Yusuf S. Eur Heart J
• 01:00
  Transcatheter mitral valve in ring implantation: a word of caution based on histopathological workup - Schmiady M, Carrel T, Sigler M, et al. Eur Heart J
  Cardiac surgery is the current gold standard for mitral valve repair. However, surgery may carry a high perioperative risk in critically ill patients. Transcatheter valve-in-ring and valve-in-valve implantation has emerged as a promising alternative in these patients, but significant residual (...)
• 01:00
  Advancing therapeutic targeting of the vulnerable plaque - Newman A, Cyr Y, Moore K. Eur Heart J
• 01:00
  Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm - Hageman S, McKay A, Ueda P, et al. Eur Heart J
  AbstractAimsThe 10-year risk of recurrent atherosclerotic cardiovascular disease (ASCVD) events in patients with established ASCVD can be estimated with the Secondary Manifestations of ARTerial disease (SMART) risk score, and may help refine clinical management. To broaden generalizability (...)
• 01:00
  Heart failure: a 70 year Odyssey - Braunwald E. Eur Heart J
• 01:00
  Proteomics for the prediction and prevention of atherosclerotic disease - Ridker PM. Eur Heart J
• 01:00
  Volunteer first responders for out-of-hospital cardiac arrest at home: the missing link for improved survival? - Malta Hansen C, Folke F. Eur Heart J

12 February

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  A comprehensive update on valvular heart disease: from mechanisms to Guidelines - Crea F. Eur Heart J

11 February

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Corrigendum to: Genetic evidence for vitamin D and cardiovascular disease: choice of variants is critical Eur Heart J
  European Heart Journal, https://doi.org/10.1093/eurheartj/ehab870.
• 01:00
  Erratum to: Leadless pacing: is this the end of the road for transvenous pacemakers? Eur Heart J
  European Heart Journal, https://doi.org/10.1093/eurheartj/ehab769.

10 February

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Improving cardiovascular magnetic resonance access in low- and middle-income countries for cardiomyopathy assessment: rapid cardiovascular magnetic resonance Eur Heart J
  AbstractAimsTo evaluate the impact of a simplified, rapid cardiovascular magnetic resonance (CMR) protocol embedded in care and supported by a partner education programme on the management of cardiomyopathy (CMP) in low- and middle-income countries (LMICs).Methods and resultsRapid CMR focused (...)
• 01:00
  Endothelial cell-derived tetrahydrobiopterin prevents aortic valve calcification - Liu Z, Dong N, Hui H, et al. Eur Heart J
  AbstractAimsTetrahydrobiopterin (BH4) is a critical determinant of the biological function of endothelial nitric oxide synthase. The present study was to investigate the role of valvular endothelial cell (VEC)-derived BH4 in aortic valve calcification.Methods and resultsPlasma and aortic valve (...)
• 01:00
  New therapeutic targets in the prevention of atherosclerotic cardiovascular disease - Crea F. Eur Heart J

9 February

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Impact of myocardial injury after coronary artery bypass grafting on long-term prognosis Eur Heart J
  AbstractAimsThe most appropriate definition of perioperative myocardial infarction (pMI) after coronary artery bypass grafting (CABG) and its impact on clinically relevant long-term events is controversial. We aimed to (i) analyse the incidence of pMI depending on various current definitions in (...)
• 01:00
  You can only change what you measure: an argument for more detailed characterization in the Fontan circulation Eur Heart J
• 01:00
  Early and late-onset syncope: insight into mechanisms - Torabi P, Rivasi G, Hamrefors V, et al. Eur Heart J
  AbstractAimsUnexplained syncope is an important clinical challenge. The influence of age at first syncope on the final syncope diagnosis is not well studied.Methods and resultsConsecutive head-up tilt patients (n = 1928) evaluated for unexplained syncope were stratified into age groups P < (...)
• 01:00
  Corrigendum to: Heart failure with preserved ejection fraction in humans and mice: embracing clinical complexity in mouse models Eur Heart J
  European Heart Journal, https://doi.org/10.1093/eurheartj/ehab389.
• 01:00
  Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality - Verbrugge F, Omote K, Reddy Y, et al. Eur Heart J
  AbstractBackgroundA substantial proportion of patients with heart failure (HF) with preserved ejection fraction (HFpEF) present with normal natriuretic peptide (NP) levels. The pathophysiology and natural history for this phenotype remain unclear.Methods and resultsConsecutive subjects (...)
• 01:00
  Interferon regulatory factor-5-dependent CD11c+ macrophages contribute to the formation of rupture–prone atherosclerotic plaques - Edsfeldt A, Swart M, Singh P, et al. Eur Heart J
  AbstractAimsInflammation is a key factor in atherosclerosis. The transcription factor interferon regulatory factor-5 (IRF5) drives macrophages towards a pro-inflammatory state. We investigated the role of IRF5 in human atherosclerosis and plaque stability.Methods and resultsBulk RNA sequencing (...)
• 01:00
  Targeted proteomics improves cardiovascular risk prediction in secondary prevention - Nurmohamed NS, Belo Pereira JP, Hoogeveen RM, et al. Eur Heart J
  AbstractAimsCurrent risk scores do not accurately identify patients at highest risk of recurrent atherosclerotic cardiovascular disease (ASCVD) in need of more intensive therapeutic interventions. Advances in high-throughput plasma proteomics, analysed with machine learning techniques, may (...)
• 01:00
  Fighting against sudden cardiac death: need for a paradigm shift—Adding near-term prevention and pre-emptive action to long-term prevention - Marijon E, Garcia R, Narayanan K, et al. Eur Heart J
  AbstractMore than 40 years after the first implantable cardioverter-defibrillator (ICD) implantation, sudden cardiac death (SCD) still accounts for more than five million deaths worldwide every year. Huge efforts in the field notwithstanding, it is now increasingly evident that the current (...)

8 February

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Sex equality or sex equity: what are we looking for in treating limb-threatening ischaemia? - Kingsmore D, Brittenden J. Eur Heart J
• 01:00
  New insights into transcatheter edge-to-edge repair: filling a gap for undertreatment of primary mitral regurgitation in the elderly? - Iung B, Urena M. Eur Heart J

4 February

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Clinical significance of epicardial fat in suspected angina pectoris: an observational study - Dadarwal A, Garg N, Kapoor A, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundEpicardial adipose tissue (EAT) is the visceral fat between pericardium and visceral epicardium and is the source of several endocrine and inflammatory mediators. It also has paracrine affects in the neighboring coronary (...)
• 01:00
  Homocysteine predicts vascular target organ damage in hypertension and may serve as guidance for first-line antihypertensive therapy - Carnagarin R, Schlaich M. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Foundation. Main funding source(s): the primary author is supported by the Australian National Heart Foundation post docctoral fellowshipOnBehalfDobney Hypertension CentreBackgroundHomocysteine is an independent risk factor for (...)
• 01:00
  Invasive validation of the different echo parameters and cut-offs among the trilogy of left ventricular filling pressure assessment guidelines: EACVI/ASE 2016, ESC 2016, HFA 2019 - Barakat A, Alsaadi A. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public hospital(s). Main funding source(s): Al-mouwasat University Hospital and University Heart Surgery Center in Damascus, Syrian Arab Republic.BackgroundLeft ventricular filling pressure assessment is a challenge. Three guidelines (...)
• 01:00
  ECG education for first-grade medical students detecting Epsilon and J waves in patients with arrhythmogenic right ventricular cardiomyopathy in comparison with specialists for arrhythmia treatment - Funabashi N, Nakamura K, Sasaki T, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundMedical students find Epsilon and J wave diagnoses by electrocardiogram (ECG) in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) difficult.PurposeTo evaluate the inter observer reliability for detecting (...)
• 01:00
  Angiographic Profiles in Persistent Non-Valvular Atrial Fibrillation Patients - Batta A, Sharma Y, Makkar K, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.OnBehalfCardiology dept. PGIMER, ChandigarhBackgroundThe relationship of atrial fibrillation (AF) with coronary artery disease (CAD) is well established. Atrial ischemia due to obstructive CAD has been identified as one of the key (...)
• 01:00
  The influence of physical rehabilitation on bone mineral density in patients with chronic heart failure before and after heart transplantation - Sujayeva V, Rudenka E, Koshlataya O, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Objectiveto estimate the influence of physical rehabilitation on bone metabolism density (BMD) in patients with heart failure (HF) before and after heart transplantation (HT).Methods. We studied 95 patients with CHF before and after (...)
• 01:00
  Cardiac resynchronization therapy in patients with true left bundle branch block : a systematic review and meta-analysis - Cheng C. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Background Cardiac resynchronization therapy has been shown to improve clinical outcomes of heart failure. Still, about 30% of the patients had no response to CRT. A stricter LBBB criteria emphasizing notched or slurred R waves was (...)
• 01:00
  Prevalence and characteristics of non-ST-segment elevation in acute myocardial infarction with insignificant coronary artery disease - Sricholwattana S, Chaipromprasit J, Kosum P. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public hospital(s). Main funding source(s): King Chulalongkorn Memorial HospitalBackground Acute myocardial infarction is mostly associated with obstructive coronary artery disease. 8% to 12% of patients have insignificant coronary artery (...)
• 01:00
  The use of bedside haemodynamic parameters to predict risk and in-hospital outcomes in non-ST elevation acute coronary syndromes: data from resource- limited settings in Iraq - Dakhil Z. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundThere is lack of data on the value of bedside hemodynamic parameters in predicting risk and outcomes in NSTE-ACS. This study aimed to assess if the following bedside haemodynamic tests : mean arterial pressure (MAP) [DBP + (...)
• 01:00
  Clinical implications of troponin-T elevations following TAVR - Imamura T, Oshima A, Onoda H, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundBaseline and post-procedural elevations in serum troponin-T levels are associated with increased morbidity and mortality following transcatheter aortic valve replacement (TAVR). However, the prognostic impact of change in (...)
• 01:00
  Single center experience of transcatheter aortic valve implantation in severe aortic stenosis: study of mid-term clinical outcome - Tey Y, Aris F, Jalaluddin M, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BACKGROUNDTranscatheter Aortic Valve Implantation (TAVI) had revolutionized the treatment and outcome of symptomatic severe aortic stenosis (AS) since its introduction. In 2009, our center performed the first TAVI in Malaysia and (...)
• 01:00
  Direct oral anticoagulant vs low molecular weight heparin for the treatment of venous thromboembolism associated with malignancy: a meta- analysis - Lastimosa H. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundVenous thromboembolism (VTE) is a major cause of morbidity and mortality in cancer patients and treatment of cancer associated thromboembolism is challenging. Low molecular weight heparin (LMWH) has been the standard of (...)
• 01:00
  Anticoagulation practices and venous thromboembolism in COVID-19 patients in a Philippine tertiary hospital - Ramos M. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.INTRODUCTIONCOVID-19 poses an increased risk for thrombosis and initiation of prophylactic anticoagulation has been shown to have mortality benefit in earlier studies. However, the use of full dose anticoagulation as prophylaxis and (...)
• 01:00
  The effects of Kaatsu training on an acute angiogenic response in post-interventional rehabilitation of peripheral arterial disease patients - Wlodarczyk A, Wachsmann-Maga A, Schonborn M, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundAtherosclerosis as the main cause of death in adults is one of the greatest challenges of modern medicine. Peripheral arterial disease (PAD) is a condition with worldwide increasing occurrence affecting more than 20% of (...)
• 01:00
  The impact of blood pressure variation on mortality and symptomatic intracerebral hemorrhage in stroke patients after thrombolytic therapy - Kotruchin P, Kliangsa-Ard H, Mitsungnern T, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public Institution(s). Main funding source(s): Faculty of Medicine, Khon Kaen UniversityIntroduction Blood pressure variation (BPV) was one of the risk factors for unfavorable stokes outcomes. However, the association between BPV and (...)
• 01:00
  Incidence of gastrointestinal bleeding after transoesophageal echocardiography in patients with gastro-oesophageal varices: a systematic review and meta-analysis - Hui R, Leung C. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionTransoesophageal echocardiography (TEE) is useful for cardiac assessment and intraoperative monitoring. However, the safety of TEE in cirrhotic patients with gastro-oesophageal varices has remained uncertain.PurposeThis (...)
• 01:00
  When type 2 diabetes coexists with atrial fibrillation in Middle Eastern patients: Clinical profiles and utilization of oral anticoagulant agents - Hammoudeh A, Alzyoud W, Ja"ara D, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.OnBehalfThe Jordan Atrial Fibrillation (JoFib) StudyBackground. Studies from different regions in the world have shown that patients with atrial fibrillation (AF) who have type 2 diabetes mellitus (T2D) have unfavorable baseline (...)
• 01:00
  Impact of preprocedural upper gastrointestinal endoscopy for pulmonary vein isolation - single-center experience of 400 patients - Grosse Meininghaus D, Kleemann T. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionMucosal esophageal lesions (ELs) are reported in 10-40% after pulmonary vein isolation (PVI) and may be precursors of (almost always lethal) atrio-esophageal fistula (AEF). Although mechanisms of lesion progression are (...)
• 01:00
  Echinacoside inhibited cardiomyocyte apoptosis and improved heart function in heart failure rats induced by isoproterenol via suppressing nadph/ros/atf6/chop associated endoplasmic reticulum stress - Ni Y, Gao L, Zhu W. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Other. Main funding source(s): Shaanxi Provincial Key Research and Development Projects (2019SF-218)BackgroundEndoplasmic reticulum (ER) stress played an essential role in the development and progression of HF due to it could induce (...)
• 01:00
  Clustering analysis based on automated electrocardiographic measurements to identify prognostically distinct phenotypes in patients hospitalized for heart failure: a retrospective cohort study - Chan J, Zhou J, Li A, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundHeart failure (HF) is a heterogeneous disease with complex structural and electrophysiological derangements of the heart. Attempts to classify HF from the electrophysiological perspective are lacking.PurposeTo use (...)
• 01:00
  In-hospital outcomes of acute heart failure according to left ventricular ejection fraction: a single-center retrospective cohort study - Han-Gla A, Viriyanukulvong K, Ariyachaipanich A. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundAcute heart failure (AHF) is a common cause of hospitalization and associated with high mortality rate. However, the study on outcomes of AHF patients classified by left ventricular ejection fraction (LVEF) in Thailand (...)
• 01:00
  Do more specific assays for B-type natriuretic peptides better predict heart failure in breathless patients than the currently used assays? - Lewis L, Raudsepp S, Whitlow J, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): Heart Foundation of New Zealand Health Research Council of New ZealandIntroductionThe cardioprotective B-type natriuretic peptide (BNP1-32) and its inactive congener N-terminal (...)
• 01:00
  Efficacy and safety of HDL/apoA-1 mimetics on human and mice with atherosclerosis: a systematic review and meta-analysis - Abudukeremu A, Li H, Sun R, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public grant(s) – National budget only. Main funding source(s): the National Natural Science Foundation of ChinaBackgroundLow high-density lipoprotein cholesterol (HDL-C) level as a residual risk factor of cardiovascular disease (CVD) is (...)
• 01:00
  Primary PCI in the very elderly: A study of outcomes in patients aged > 85 years with STEMI - Jariwala P, Jadhav K. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundPrimary percutaneous coronary intervention (PPCI) as management for acute STEMI is a well-established, evidence-based treatment offered across India. Evidence of benefit in the very elderly is sparse. With an aging (...)
• 01:00
  Cost and prescription trends of P2Y12 inhibitors in Australia over the last decade - Abrahams T, Brown A, Pol D. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundCoronary artery disease (CAD) remains one of the leading causes of mortality worldwide and in Australia, and places significant burden on healthcare costs. [1,2] Dual antiplatelet therapy (DAPT) is guideline therapy (...)
• 01:00
  The effect of remote ischemic post-conditioning on left ventricular ejection fraction in STEMI patients undergoing primary percutaneous coronary intervention - Fadil M. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Background/IntroductionPrimary Percutaneous Coronary Intervention (PPCI) in ST-Segment Elevation Myocardial Infarction (STEMI) is an effective method to limit the infarct area, reduce clinical symptoms, and improve clinical (...)
• 01:00
  Left main PCI with second-generation DES: a single-centre experience - Jariwala P, Jadhav K. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundTo characterise patients and procedures with left main (LM) percutaneous coronary intervention (PCI) and to evaluate their outcomes.MethodsSingle-centre, retrospective study performed from January 2018 to December 2019 in (...)
• 01:00
  Analysis of clinical features and coronary angiography in 10 patients with de winter syndrome - Ni N. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.OnBehalfGuohua NiObjectiveTo investigate the clinical characteristics and electrocardiogram (ECG) changes of patients with de winter syndrome, so as to enhancing the awareness of de Winter ECG pattern and conducting early emergency (...)
• 01:00
  Circulating extracellular vesicles correlate with nocturnal blood pressure and vascular organ damage and may serve as an integrative biomarker of vascular health. - Lugo Gavidia L, Burger D, Robinson S, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public Institution(s). Main funding source(s): National Council on Science and Technology, Mexico (CONACYT).Background Elevated blood pressure (BP) has been associated with increased levels of circulating extracellular vesicles (EVs) (...)
• 01:00
  Study on the correlation between ambulatory blood pressure and left atrial diameter in patients with treated and controlled office hypertension - Zhang L, Zhang X, Song W, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Background Patients suffered from different kinds of target organ damage even after years of standardized treatment in clinic. PurposeTo explore the relationship between ABPM and LAD in patients with treated essential (...)
• 01:00
  Serum uric acid is positively associated with systolic and diastolic blood pressure in young adults - Correa T, De Oliveira I. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public grant(s) – National budget only. Main funding source(s): Science and Technology Department of the Brazilian Ministry of Health.IntroductionUric acid is the final product of purine metabolism, and its increase can be related to (...)
• 01:00
  A survey-based comparison of cardiovascular health risk behaviours in Indian men and women during the pandemic - Chockalingam P, Natarajan V, Sekar T. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundCardiovascular disease (CVD), the leading cause of mortality globally, is caused by a combination of behavioral, clinical and genetic risk factors. The rising prevalence of unhealthy diet, inadequate exercise, psychosocial (...)
• 01:00
  Epidemiology of obstructive sleep apnea in older patients with stable cardiovascular disease and chronic kidney disease - Efremova E, Shutov A, Serov V, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Obstructive sleep apnea (OSA) is diagnosed late, especially in older people. The presence of chronic hypoxia and glomerular hypertension decrease renal function in patients with OSAS, which causes the progression of chronic kidney (...)
• 01:00
  Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) inhibitors and adverse cardiovascular events: a population-based study - Lee S, Zhou J, Lakhani I, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.OnBehalfCardiovascular Analytics GroupBackgroundProgrammed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) inhibitors are major classes of immune checkpoint inhibitors that are increasingly used for cancer treatment. However, (...)
• 01:00
  Serial echocardiography assessment and clinical outcomes among pregnant women with Tetralogy of Fallot - Hon N, Wu M, Yu S, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Following advancements in intracardiac repair of Tetralogy of Fallot (TOF), a greater proportion of patients survive well beyond child-bearing age. Pulmonary regurgitation (PR) and subsequent progressive right ventricular dilatation (...)
• 01:00
  Role of prenatal cardiovascular magnetic resonance imaging in determining pregnancy risk in repaired Tetralogy of Fallot patients - Hon N, Wu M, Yu S, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Addressing pregnancy risks poses as a new challenge among women with repaired tetralogy of Fallot (TOF). The high-output state of pregnancy may predispose women to late complications of repaired TOF. However, guidelines regarding (...)
• 01:00
  Accuracy of global longitudinal and territorial longitudinal strain in determining myocardial viability in out of window period Anterior wall myocardial infarction patients - Batta A, Sharma Y, Makkar K, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundPrimary percutaneous intervention remains the principal treatment modality for anterior wall myocardial infarction (AWMI). However, a large fraction of patients especially in the developing countries present outside the (...)
• 01:00
  OCT-guided left-main PCI, a retrospective single-center analysis - Jariwala P, Jadhav K, Jadhav K. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundIt is known that PCI is associated with non-optimal stent implantation utilizing angiography for only left main lesions as well as for bifurcation lesions and is characterised by a high risk of adverse long-term effects. (...)
• 01:00
  High power short duration (HPSD) versus lower power longer duration (LPLD) atrial fibrillation ablation: a multi-centre randomised controlled trial (HiLo-HEAT study) - Chieng D, Sugumar H, Segan L, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Background Lower power (25W) longer duration (LPLD) radiofrequency (RF) ablation has conventionally been used on the posterior wall during pulmonary vein isolation (PVI) for atrial fibrillation (AF), to attenuate the risk of (...)
• 01:00
  A multicentre survey of paediatric out-of-hospital cardiac arrest incidence, aetiology, and survival in New South Wales over an 11-year period - Youssef D, Singh A, Ayer J, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionOut-of-hospital cardiac arrest (OOHCA) is commonly associated with pulseless ventricular tachycardia and ventricular fibrillation (VT/VF) and cardiac aetiologies. One New South Wales (NSW) ambulance registry reported(1) (...)
• 01:00
  Acute procedural outcomes of his bundle pacing with or without electrophysiology mapping system: a multicenter study - Loo G, De Leon J, Seow S, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionHis bundle pacing (HBP) is associated with improved clinical outcomes compared to right ventricular apical pacing. However, it can be technically challenging and may result in prolonged fluoroscopy and procedural (...)
• 01:00
  Clinical value of the HATCH score for predicting adverse outcomes in patients with heart failure - Shibata N, Kondo T, Morimoto R, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundThe HATCH score is employed as a risk assessment tool for atrial fibrillation (AF) development. However, the impact of the HATCH score on the long-term adverse outcomes in patients with acute heart failure (AHF) is (...)
• 01:00
  Prognostic value of machine learning for acute heart failure - Shimizu M, Miyazaki H, Cho S, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundAt onset of acute heart failure (AHF), various clinical fundamental parameters including vital sign, laboratory data, or initial treatment were investigated, and we can roughly estimate the prognosis. However, machine (...)
• 01:00
  An echocardiographic algorithm for predicting coronary artery disease: is it time to establish one? - Barakat A, Alsaadi A. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public hospital(s). Main funding source(s): Al-mouwasat University Hospital and University Heart Surgery Center in Damascus, Syrian Arab Republic.BackgroundCoronary artery disease (CAD) is a major clinical issue. CAD affects left (...)
• 01:00
  Differential association between significant coronary stenosis and cardiac troponin T serial algorithms in renal dysfunction patients diagnosed with non-ST-segment elevation acute coronary syndromes - Kotruchin P, Tangpaisarn T, Srimakam N, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public Institution(s). Main funding source(s): Faculty of Medicine Khon Kaen UniversityBackgroundHigh-sensitivity cardiac troponin T (hs-cTnT) is recommended for diagnosing non-ST segment elevation acute coronary syndromes (NSTE-ACS). (...)
• 01:00
  Knowledge and attitudes amongst internal medicine clinicians in referring valvular heart disease patients : a multi-centre survey study - Raja Shariff R, Ibrahim K, Zainal Abidin H, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundWith advancement in valvular interventions, outcomes of valvular heart disease (VHD) patients have improved dramatically. However, very little is known regarding levels of knowledge and attitudes amongst non-cardiology (...)
• 01:00
  Infective endocarditis post-transcatheter aortic valve replacement: a systematic review of epidemiology, clinical findings and prognosis - Jaiswal V, Jaiswal A, Ishak A, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundTranscatheter aortic valve replacement (TAVR) is a minimally invasive, catheter-based procedure to replace calcified narrow aortic valves. Available data on prosthetic valve endocarditis (PVE) post TAVR is limited to small (...)
• 01:00
  Prognostic value of pre-operative left atrial strain on composite endpoint in patients received aortic valve replacement for severe aortic stenosis: a retrospective cohort study - Tsui L, Yiu K, Tse H, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.ObjectiveSevere aortic stenosis (AS) is the most common primary valvular heart disease, treatable only by aortic valve replacement (AVR). Current literatures have shown that severe AS may precede atrial dysfunction which predicts (...)
• 01:00
  Hemodynamic change in patients with hypertrophic obstructive cardiomyopathy before and after alcohol septal ablation using 4D flow magnetic resonance imaging: a retrospective observational study - Suwa K, Akita K, Iguchi K, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public grant(s) – National budget only. Main funding source(s): Ministry of Education, Science, Sports and Culture of Japan, Grants-in-Aid for Scientific ResearchBackgroundThe hemodynamics in the left ventricle (LV) and the ascending aorta (...)
• 01:00
  Bridging to warfarin with apixaban versus conventional heparin: an open label, pilot, randomized controlled trial - Dangploy T, Wongvipaporn C. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Other. Main funding source(s): Queen Sirikit Heart center of the Northeast of ThailandBackground : Despite of non-vitamin K antagonist oral anticoagulants (NOACs) is a preferred oral anticoagulant but in limited-resource country, warfarin (...)
• 01:00
  Prediction of in-hospital mortality by using get with the guideline-heart failure (GWTG-HF) risk scores in patients hospitalized with heart failure - Mahmood M, Banerjee S. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public grant(s) – National budget only. Main funding source(s): University Grants Commission BangladeshBackgroundPrognostic stratification using readily available clinical data can assist clinical decision making in heart failure. Get with (...)
• 01:00
  Incidence, clinical correlates and associated outcomes of dementia in heart failure: a population-based cohort study - Ren Q, Teng T, Wang T, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundDementia, in the setting of heart failure (HF), portends poorer outcomes and poses great challenges in its clinical management.PurposeWe investigated the incidence, types, clinical correlates, and the prognostic impact of (...)
• 01:00
  A single-centre analysis of in-stent restenosis after left main stenting - Jariwala P, Jadhav K. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundPercutaneous coronary interventions (PCI) can be the standard of care for left main (LM) coronary artery disease. In-stent restenosis (ISR) is a rare complication and is associated with patient- and procedure-specific (...)
• 01:00
  Aspirin vs. Clopidogrel as a Chronic maintenance monotherapy after PCI in patients with high ischemic risk and high bleeding risk: Subgroup analysis of the HOST-EXAM trial - Park K, Kang J, Koo B, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.OnBehalfon behalf of the HOST-EXAM investigatorsBackgroundThe HOST-EXAM randomized clinical trial recently performed a comparison of clopidogrel monotherapy vs. aspirin monotherapy in patients requiring indefinite antiplatelet (...)
• 01:00
  Relationship of mean platelet volume to severity of coronary atherosclerosis in non-ST-segment myocardial infarction - Bin Waleed K, Tse G, Wang L, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundPlatelets play a crucial role in thrombotic mechanism. Mean platelet volume (MPV) is primarily indicator of platelet activation and its measurement is easy and time-effective. The MPV is associated with adverse cardiac (...)
• 01:00
  Short- and long-term outcomes in patients with right ventricular infarction according to modalities of reperfusion strategies in China: data from China Acute Myocardial Infarction (CAMI) Registry - Mengjin H, Yuejin Y, Xiaojin G. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public grant(s) – National budget only. Main funding source(s): Twelfth Five-Year Planning Project of the Scientific and Technological Department of ChinaPurpose We sought to investigate the short- and long-term outcomes in patients with (...)
• 01:00
  Clinical manifestation of coronary pulmonary arterial fistula diagnosed by cardiac computed tomography - Funabashi N, Kobayashi Y. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Background Coronary pulmonary arterial fistula (CPAF) may cause enlargement of an aneurysm, which may rupture or compress other organs, or occurrence of steal phenomenon of coronary arterial (CA) blood flow. We hypothesize that there (...)
• 01:00
  Risk stratification and prognosis in pulmonary arterial hypertension: the Singapore experience - Teoh J, Yap J, Ong Z, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Aims & Background: Guidelines recommend the risk stratification of patients with pulmonary arterial hypertension (PAH) at baseline and on follow-up, so as to guide the management and titration of therapy in these patients. This (...)
• 01:00
  Intravenous epoprostenol therapy in the treatment of pulmonary arterial hypertension: the Singapore experience - Choo J, Yap J, Ismail A, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundPulmonary arterial hypertension (PAH) is a progressive disease with significant morbidity and mortality. While intravenous (IV) Epoprostenol, a prostacyclin analogue, has been shown to improve exercise tolerance, symptoms, (...)
• 01:00
  The association between neutrophil to lymphocyte ratio and echocardiographic parameters in hospitalised adults with COVID-19 - a retrospective analysis - Agarwal R, Priyonugroho G, Hertine S, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundThe neutrophil to lymphocyte ratio (NLR) is an inflammatory biomarker with prognostic value in several cardiovascular conditions. Hyperinflammation contributes to severe coronavirus disease 2019 (COVID-19), which is (...)
• 01:00
  Correlation of cardiac biomarkers with computed tomography severity score in COVID-19 patients - Rivera R, Cuenza L, Razon-Cuenza T. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.INTRODUCTIONA vast number of COVID-19 cases have been reported worldwide since the initial outbreak in China, and the disease has since become a global pandemic. Knowledge on this predominantly respiratory illness is evolving with (...)
• 01:00
  Learning curve of visually-guided laser balloon ablation of paroxysmal atrial fibrillation - Kondo Y, Nakano M, Kajiyama T, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundThe visually-guided laser balloon (VGLB) is a compliant, variable-diameter balloon that delivers laser energy around the pulmonary vein (PV) ostium under real-time endoscopic visualization. However, limited data exist in (...)
• 01:00
  Alternative method of adenosine administration in paroxysmal supraventricular tachycardia - Tangsuwanaruk T, Daengbubpha P, Wittayachamnankul B, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public Institution(s). Main funding source(s): Faculty of Medicine, Chiang Mai University Research FundBackgroundAn intravenous adenosine with a double syringe technique is an essential treatment in a patient with paroxysmal (...)
• 01:00
  J waves reaching to equal or more than 2 of 3 LV inferior wall leads may predict the presence of organized myocardial fibrotic or fat change in survivors of ventricular fibrillation - Funabashi N, Kobayashi Y. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundThe distribution of J waves and the presence of organized left ventricular (LV) myocardial damage may be related in survivors of ventricular fibrillation (VF).PurposeTo predict the presence of organized myocardial damage (...)
• 01:00
  Comparison of sites of wall thickening and abnormal late enhancement on cardiac CT and magnetic resonance imaging with electrocardiography findings in patients with confirmed cardiac amyloidosis - Funabashi N, Kobayashi Y. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundLeft ventricular (LV) wall thickening and diastolic dysfunction on a transthoracic echocardiogram (TTE) without a high voltage R wave on V5 leads on an ECG leads to a diagnosis of cardiac amyloidosis. A final diagnosis is (...)
• 01:00
  Implication of current ASE/EACVI left ventricular diastolic function classification in predicting 2-year MACE in asymptomatic patients with diabetes and hypertension - Foo D, Lam K, Igo M, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public grant(s) – National budget only. Main funding source(s): Ministry of Health MalaysiaBackgroundLeft ventricular diastolic dysfunction (LVDD) has been shown to be more prevalent in patients with diabetes, and once progress to overt (...)
• 01:00
  Left main coronary artery dimension and variation in Thai population - Siriwiwattana T. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Objectives The aim of our study was to determine the length, proximal and distal dimension of the left main coronary artery (LMCA) in Thai population with normal LMCA, from coronary computed tomography angiography (...)
• 01:00
  Identification of hemodynamically significant coronary artery disease with stress myocardial blood flow ratio by dynamic CT perfusion studies - Maqsood H, Ashraf T, Younus S, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionCoronary computed tomographic angiography (CTA) is an accepted noninvasive tool with high diagnostic accuracy for the evaluation of coronary artery disease (CAD). However, coronary CTA is limited in that it does not (...)
• 01:00
  Characterizing patients with newly diagnosed atrial fibrillation compared to those with established atrial fibrillation: data from the CODE-AF registry - Choi J, Lee S, Choi E. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Foundation. Main funding source(s): Korean Healthcare Technology R&D project funded by the Ministry of Health & WelfareOnBehalfCODE-AF investigatorBackground/Introduction: The characteristic of atrial fibrillation (AF), such as (...)
• 01:00
  The impact of socioeconomic deprivation on the risk of atrial fibrillation in patients with diabetes mellitus: a nationwide population-based study - Han M, Lee S, Choi E, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundAlthough the prevalence of atrial fibrillation (AF) is increasing worldwide, little is known about the exact risk factors of AF; and the disease"s association with socioeconomic status (SES) is under debate.PurposeThis (...)
• 01:00
  A short and long-term outcomes of heart failure with midrange and preserved ejection fraction; developing countries perspective - Leesutipornchai T, Puwanant S, Siwamogsatham S, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundHospitalization and mortality are common among patients with heart failure (HF). However, evidence of outcomes in HF patients classified by left ejection fraction (LVEF) is limited, especially in Thailand.MethodsThis is a (...)
• 01:00
  Chronic kidney disease begets heart failure and vice versa; temporal associations between heart failure events in relation to incident chronic kidney disease - Wu M, Teng T, Tay W, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundDiabetes, chronic kidney disease (CKD) and heart failure (HF) are fast-growing causes of morbidity and mortality worldwide. Diabetes is an optimal model to study the inter-play of cardiovascular disease and renal (...)
• 01:00
  MicroRNA 155:145 ratio as a marker of atherogenic tilt manifested across different age groups and risk factor profiles - Banerjee A, Roy D, Mazumdar H, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Background Differential expression of microRNAs is critical in the genesis and progression of atherosclerosis. MiR145 has atheroprotective role through improved homeostasis of smooth muscle cells (SMC). MiR155 is pro-atherogenic due (...)
• 01:00
  Association of Body mass index and clinical outcomes in patient with coronary artery disease undergoing percutaneous coronary intervention - Lin T, Leu H. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundMost of the world"s population lives in countries in which overweight status and obesity issues cause more morbidity and mortality than underweight status. Mortality increased as BMI increased above 25 kg/m², and the lowest (...)
• 01:00
  Demographic analysis and clinical outcomes of COVID-19 and myocardial infarction from a tertiary care centre in south India - Kongara R, Sankaran R, Muralidharan T, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Back ground – COVID-19 is reported in India from March 2020. It is known to cause myocarditis , arrythmias and heart failure. COVID-19 infection has been proposed to be associated with myocardial infarction.PURPOSE–We intent to study (...)
• 01:00
  Comparison of VWF-ADAMTS13 axis involvement in atrial fibrillation and sinus rhythm in patients with ST-elevation myocardial infarction - Osawa T, Ito Y, Nakano K, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Background Previous studies have shown that von Willebrand factor (VWF) increases, and a disintegrin-like and metalloproteinase with thrombospondin type-1 motifs 13 (ADAMTS13) decreases in myocardial infarction. Few studies have (...)
• 01:00
  Risk scores in predicting adverse events after an acute coronary syndrome - Duarte F, Barradas M, Barradas M, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionST-segment elevation myocardial infarction (STEMI) is a serious event that usually occur in patients with cardiovascular risk factors and is associated with great morbidity and mortality.PARIS ischemic risk score and TIMI (...)
• 01:00
  Hemorrhagic risk scores in hospitalized patients with acute coronary syndrome: can they (only) predict bleeding events? - Duarte F, Barradas M, Oliveira L, et al. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionAcute coronary syndrome (ACS) is a life-threatening condition and its therapeutic approach increases the risk of important bleeding events which are associated with a worse prognosis. Along with hemorrhagic events, a drop (...)
• 01:00
  Standardized LocSSIPs improves risk prevention for in-patient angioplasty in tertiary care hospital - Kyaw K. Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.OnBehalfacute cardiovascular careIntroductionThere are no established ESC/NICE guidelines for acceptable Safety Checklists in invasive coronary angiogram. A lack of Quality Assurance Checklists that is indicated by WHO guidelines for (...)